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ABSTRACT
This thesis is focused on the development of novel hybridized biomaterials for
applications in tissue engineering and controlled drug delivery. Two types of materials
used in my research are biopolymers and nanomaterials. Hyaluronic acid (HA), a natural
polymer commonly found in extracellular matrix (ECM), was the primary polymer used in
my research due to biocompatibility, biodegradability and the ease of manipulation to offer
a wide range of physical and mechanical properties. Meanwhile, the nanomaterials,
including Tobacco mosaic virus (TMV), gold nanorods and graphene, provide attractive
properties, such as a nanoscale topography, biochemistry, high surface area, and special
chemical and electrical properties. These properties could promote cell response, and allow
the nanomaterials to react with a myriad of biological small molecules. Hence, in this
thesis, we aimed to integrate these two types of materials to create a new type of
biomaterials, and provide ideal properties that can leverage the tissue regeneration and
targeted drug delivery for various treatment applications.
Previously, our research group has found the intriguing effect of TMV on bone
differentiation of mesenchymal stem cells (MSCs). We demonstrated that TMV could
promote MSC osteogenesis via upregulating bone morphogenetic protein-2 (BMP-2) gene
expression, a common gene used to enhance cartilage differentiation. This discovery
combined with the clinical demand for cartilage tissue repair, which is limited by the
minimum self-healing capacity of cartilage, inspired us to design a hybrid TMV scaffold
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in a simple injectable form, using thiol-ene “click” chemistry, to promote the MSC
differentiation to cartilage. We demonstrated that cysteine-inserted TMV mutants
(TMV1cys), containing thiol functional groups, could successfully crosslink to
methacrylated hyaluronic acid (MeHA) polymers by thiol–ene “click” chemistry and form
hydrogels under physiological conditions. The resulting hydrogels promoted in vitro
chondrogenesis of MSCs by upregulating BMP-2 and enhancing collagen accumulation.
In addition, incorporation of RGD-inserted TMV mutants (TMV-RGD1) in the HA
hydrogels further promoted the in vitro chondrogenesis of BMSCs. Meanwhile,
incorporation of gold nanorods, which provide similar size and shape as TMV, HA
hydrogels showed no impact on the in vitro chondrogenesis. These results implied that the
influences of nanoscale topography and biochemistry provided by TMV and TMV-RGD
play critical roles in directing encapsulated MSC chondrogenesis.
To better mediate new cartilage tissue formation, the physical and mechanical
properties of the HA hydrogels were further optimized by varying the structures of thioltailored crosslinker molecules using dithiothreitol (DTT), 4-arm polyethylene glycol
(PEG), and a multi-arm polyamidoamine (PAMAM) dendrimer. Chondrogenesis and
osteogenesis of MSCs were highly enhanced in 4-arm PEG-crosslinked HA hydrogels, as
measured by chondrogenic markers, glycosaminoglycan (GAG) and collagen
accumulation, and osteogenic markers, alkaline phosphatase activity, and calcium
deposition. It implied that the differentiation performance of MSCs directly correlated to
the mechanical stiffness, permeability, pore size, porosity and chemistry of crosslinkers.
The 4-arm PEG-crosslinked HA hydrogels seemingly mimicked the architecture of real
cartilage and bone closer than other hydrogels.
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Aside from the application in tissue engineering, we developed a graphene oxide
(GO)-hybridized HA-based hydrogel for perivascular drug delivery. The nanoscale GO
was used as a novel nanocarrier for controlled drug delivery, owing to its high loading
capacity of drugs resulting from the aromatic structure. HA serves as a biodegradable
macroscale polymeric scaffold, making the prepared GO nanocarriers localized and stable
in different microenvironments. The nanocarrier was firstly synthesized by attaching
Senexin A (SNX), a kinase inhibitor and a possible anti-tumor drug, to GO via strong π–π
interaction, followed by the in situ encapsulation of GO-SNX with HA-based hydrogel.
The results of in vitro testing indicate high loading of SNX onto GO, and subsequent slow
release of SNX within the therapeutic window. The slow release of SNX closed correlates
to the loading-ratio of GO to SNX. With the in vitro results, we have demonstrated that the
SNX loaded-GO hybridized HA hydrogel could be successfully attached to the
decellularized scaffolds and form hydrogels under physiological condition. The hybridized
materials provided a good biocompatibility and no impact on the proliferation and
migration of vessel smooth muscle cells (VSMCs). More importantly, it could inhibit the
dedifferentiation of VSMCs in the same manner as the SNX treatment.
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CHAPTER 1
THE DEVELOPMENT OF IN SITU HYBRIDIZED
BIONANOPARTICLE-HYALURONIC ACID HYDROGELS AS CELL
SCAFFOLDS FOR TISSUE ENGINEERING1
1.1 INTRODUCTION
The pursuit to cartilage tissue engineering is prompted by the limitation of current
clinical methods to repair the defected cartilage1 as well as the limitation in self-healing
capacity of cartilage.2-4 The basic principle of cartilage tissue engineering is isolation of
appropriate cells that are proliferated in a 3D scaffold, subsequently implanted into the site
of injury, and regenerated the defected cartilage tissue. Bone marrow derived stem cells
(BMSCs) are promising cell sources for cartilage tissue engineering since they can be
easily isolated, cultured, and differentiated into matrix-producing chondrocytes.5-7
Importantly, the use of BMSCs can lessen the limitations of using autologous chondrocytes
which are donor-site morbidity and limited matrix production after cell expansion.8,9
However, promoting stem cell chondrogenesis is still a key to accomplish a successful
cartilage repair.
Recently, we reported that the use of Tobacco mosaic virus (TMV) and other plant
virus particles as cell-supporting materials could rapidly induce BMSCs toward osteogenic

1

Portions of this chapter were adapted with permission from Maturavongsadit, P.; Luckanagul, J. A.;
Metavarayuth, K.; Zhao, X.; Chen, L.; Lin, Y.; Wang, Q. Biomacromolecules 2016, 17, 1930-1938.
Copyright (2016) American Chemical Society (Appendix A).
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differentiation.10-14 TMV is a rod-like plant virus that is 300 nm in length, with an average
diameter of 18 nm, and consists of 2130 identical coat protein subunits assembled in a
helical manner around single-stranded RNA (Figure 1.1). Its surface chemistry can be
tailored through chemical or genetic modification.15,16 For example, a TMV mutant
genetically engineered to express a coat protein cysteine residue, TMV1cys, has been
broadly used in the different applications.17,18 Our previous studies demonstrated that the
TMV coated on two-dimensional (2D) substrates could enhance osteogenesis of BMSCs
through an upregulation of bone morphogenetic protein-2 (BMP-2) expression, a key
morphogenetic protein involved in bone and cartilage formation (Figure 1.2).13 TMV was
also incorporated in a 3D alginate-based hydrogel system which aimed to mimic a native
bone microenvironment. It was found that the TMV embedded macroporous alginate
hydrogel could enhance osteogenesis in vitro and in vivo (Figure 1.3).19,20 The results from
these earlier studies confirmed that TMV plays a critical role in accelerating the
osteogenesis process of BMSCs in both 2D and 3D environments; however, it is still
unknown whether similar events can be translated to chondrogenesis in 3D scaffolds.

Figure 1.1. TMV structure. (A) Computer reconstructed image showing TMV structure
using PyMOL with coordinates from Protein Data Bank. The single stranded RNA inside
TMV particle is represented by the black helix. The tyrosine 139 (Y139) residues of
individual TMV coat proteins subunits are colored in blue while all other amino acid
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residues are washed out in gray. (B) An enlarged portion of TMV coat protein [from the
boxed area in (A)], showing possible distances (dashed red lines, measured in Angstroms)
among the blue Y139. Reprinted from Sitasuwan, P.; Lee, A. L.; Li, K.; Nguyen, H. G.;
Wang, Q. RGD-conjugated rod-like viral nanoparticles on 2D scaffold improve bone
differentiation of mesenchymal stem cells 2014, 2:31. Copyright (2014) Sitasuwan, Lee,
Li, Nguyen and Wang, Open Access. Published by Creative Commons Attribution License.

Figure 1.2. The promotion of in vitro BMSC osteogenesis by the TMV coated on 2D
substrates. (A) Quantification of BMP2 protein expression at 8 and 24 hours normalized to
the cell number by ELISA. The values are expressed as fold change compared to cells on
tissue culture plate (TCP) before osteoinduction. The error bars denote ±1 S.D. ** p < 0.05
based on ANOVA. (A) Alkaline phosphatase activity of cells under three different
conditions. (C) Absorbance at 548 nm normalized to the cell number to indicate a relative
amount of calcium deposit at day 14 stained by alizarin red solution (**p < 0.05 based
ANOVA). The error bars denote ±S.D. Reprinted with permission from Sitasuwan, P.; Lee,
L. A.; Bo, P.; Davis, E. N.; Lin, Y.; Wang, Q. A Plant Virus Substrate Induces Early
Upregulation of BMP2 for Rapid Bone Formation. Integrative biology : quantitative
biosciences from nano to macro 2012, 4, 651-660. Copyright (2012) Royal Society of
Chemistry (Appendix B).
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Figure 1.3. The promotion of in vitro BMSC osteogenesis and in vivo bone regeneration
by the TMV and TMV-RGD1 embedded macroporous alginate hydrogels (TMV-PAH,
RGD-PAH). (A) In vitro ALP activity assay was performed on days 3, 7, and 14 of
osteogenic culture. Values expressed are mean (n = 3) ± S.D., ≠*paired equal variance
Student t test, p < 0.05. (B) Calcium deposition quantified by ICP-OES on day 6 after
background subtraction from control samples with no cells. Values expressed are mean (n
= 3) ± SEM, *paired equal variance Student t test, p < 0.05. Reprinted with permission
from Luckanagul, J.; Lee, L. A.; Nguyen, Q. L.; Sitasuwan, P.; Yang, X.; Shazly, T.; Wang,
Q. Porous Alginate Hydrogel Functionalized with Virus as Three-Dimensional Scaffolds
for Bone Differentiation. Biomacromolecules 2012, 13, 3949-3958. Copyright (2012)
American Chemical Society (Appendix C). (C) Bone regeneration in critical size defect
areas with porous hydrogel bone substitutes. The bone volume regenerated in each type of
hydrogel was quantified using microcomputed tomography (microCT). Values expressed
are the means (n = 6 for PAH and n = 5 for TMV-PAH and RGD-PAH) ± SEM. (D)
Histological analysis of regenerated bone at defect sites filled with hydrogel implants after
10 weeks of implantation. The sections were stained with Masson’s trichrome and imaged
with 100× magnification. The regenerated bone was characterized by the presence of a
collagen-rich matrix stained blue. The inset pie charts represent the number of rats that
developed different degrees of bone regeneration at the defect site. Reprinted with
permission from Luckanagul, J. A.; Metavarayuth, K.; Feng, S.; Maneesaay, P.; Clark, A.
Y.; Yang, X.; García, A. J.; Wang, Q. Tobacco Mosaic Virus Functionalized Alginate
Hydrogel Scaffolds for Bone Regeneration in Rats with Cranial Defect. ACS Biomaterials
Science & Engineering 2016, 2, 606-615. Copyright (2016) American Chemical Society
(Appendix C).
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In situ-forming hydrogels have been recognized as promising biomaterials in
cartilage-repairing applications21 because it is possible to inject pre-gel solutions into
cartilage damage through minimally invasive surgical procedures and fill irregular shape
defects before gelation.22,23 Among various starting materials, hyaluronic acid (HA) is one
building block of particular interest because it is biocompatible, biodegradable, and
functional in the synovial fluid of cartilage.24 HA binds specifically to the proteins in the
extracellular matrix (ECM), on the cell surface, and within the cell, and hence play a role
in stabilizing cartilage matrix,25,26 cell motility,27,28 function of growth factor,29 and
inflammation.30 Clinically, HA is commonly used as a viscosupplementation for treatment
of knee osteoarthritis (OA), in which HA is injected into the knee joint for the alleviation
of joint pain and improvement of joint function.31-33 More importantly, HA hydrogels have
been developed that could be formed, in situ, under physiological conditions, and the
structure of HA can be chemically modified through its hydroxyl or carboxyl group to alter
the properties of the resulting materials.34,35
Taken together, the goal of this study is to develop the in situ TMV-based HA
hydrogels for cartilage tissue engineering applications. HA was firstly modified with
methacrylic anhydride under basic conditions to form methacrylated HA (MeHA).
TMV1cys was used to crosslink into the in situ MeHA hydrogels via thiol–ene coupling
reaction. Physical properties of the TMV-based HA hydrogels were characterized and
compared to the unhybridized HA hydrogels. Cytocompatibility was observed when the
BMSCs were cultured in the TMV-based HA hydrogels.
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1.2 RESULTS AND DISCUSSION
1.2.1 Synthesis of TMV-Based HA Hydrogels
Before fabrication of the hydrogels, the stabilities of the purified TMV1cys were
confirmed by TEM analyses (Figure 1.4). As shown in Figure 1.5, HA macromers (47 kDa
MW) were firstly modified with methacrylates to enable cross-linking via thiol–ene
reaction to form hydrogels. The modification was performed by a simple one-step reaction
with methacrylic anhydride. An excess of methacrylic anhydride with respect to HA was
used because of the limited solubility and potential hydrolysis reaction of methacrylic
anhydride in an aqueous medium.36,37 The higher molecular weight HA provided a higher
viscosity of the HA solution which reduced the reaction rate. We found that the 47 kDa
HA was practical for the experiment since it gave optimum viscosity and modularity in a
wide range of percent degree of methacrylation. In the report by Chung et al., they also
supported the use of relatively small HA macromer (approximate 50 kDa) to fabricate
hydrogels for continued development of cartilage since it most resembled the properties of
native cartilage when compared to the hydrogels from the larger HA (tested up to 1100
kDa).38,39 The 1:6 molar ratio of HA monomer and methacrylic anhydride consistently
generated 40–50% degree of modification of HA backbones, as determined by 1H NMR
(Figure 1.6). TMV1cys, providing cysteine residues on its coat proteins,40 was covalently
conjugated to methacrylated HA backbone via a Michael addition reaction. DTT was then
cross-linked to the methacrylated HA functionalized with TMV1cys solution to create the
hydrogel via the same thiol–ene reaction, which can be completed in an aqueous medium
at physiological temperature and pH in the presence of proteins or cells;41-43 therefore, it
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can be used for in vivo applications. The illustration and physical appearance of the in situ
TMV-based HA hydrogels are shown in Figure 1.7.

Figure 1.4. Transmission electron micrograph of TMV1cys.

Figure 1.5. Schematic illustration of the synthesis of TMV-based HA hydrogels (A) HA
modification with methacrylic anhydride to form the methacrylated HA (MeHA); (B)
Synthesis of the TMV-based HA hydrogel.
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Figure 1.6. 1H NMR spectra of methacrylated HA with approximate 40% degree of
modification.

Figure 1.7. Illustration of the in situ hydrogel formation. (A) The pre-hydrogel mixture
with TMV1cys (left) and without TMV1cys (right). (B) Injectable simulation of prehydrogel mixture through needle 20G. (C) The TMV1cys-based HA hydrogel (left) and
HA hydrogel (right) after gelation for 2 h.
1.2.2 Structure of TMV-Based HA Hydrogels
MALDI-TOF MS was used to confirm the cross-linking between TMV1cys and the
MeHA backbone after the formation of the hydrogel. The TMV-Cys-HA hydrogel was
digested

using

hyaluronidase

(HAase),

which

could

randomly

cleave

β-N-

acetylhexosamine-[1 → 4]glycosidic bonds in HA before it was processed to run MALDITOF MS analysis. Figure 1.8A demonstrated that the TMV-Cys-HA hydrogel obtained
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pronounced peaks at 19652 m/z in addition to the peak of original TMV1cys coat protein
(around 17630 m/z). The mass difference subtracted from the TMV1cys peak was
calculated, and the possible structure of the TMV1cys-based HA hydrogel was proposed
in Figure 1.8B. It showed that TMV1cys covalently interacted with the backbone of
polymer. However, the degree of HA conjugation to the TMV1cys was hardly quantified
since the weight percentage of TMV1cys comparing to HA polymer and other components
in the hydrogel system is very small.

Figure 1.8. Interaction of TMV1cys and its structural integrity in HA hydrogel. (A)
MALDI-TOF spectra compared the m/z profiles of TMV1cys-based hydrogel after enzyme
digestion of HA backbone (top panel) with the virus alone (middle panel) and with the
control HA hydrogel (last panel). (B) The proposed structure of TMV1cys-based HA
hydrogel from MALDI-TOF analysis, the TMV1cys covalently interacted with the
polymer backbone.
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The existence of TMV1cys particles in the MeHA hydrogel was confirmed by AFM
images. Figure 1.9A showed the height profile of TMV1cys particles on the silicon wafer
substrate coated with the TMV-Cys-HA hydrogel, which had the same appearance with
wild-type TMV observed by AFM. Additionally, Figure 1.9B revealed that intact
TMV1cys particles still remained in the TMV-Cys-HA hydrogel after keeping more than
6 months at room temperature.

Figure 1.9. Atomic force microscopy height image of the TMV1cys-based HA hydrogel,
showing the presence of TMV1cys intact particles in the hydrogel right after gelling (A),
and after storage for approximate 6 months (B).
The microstructure of the freeze-dried TMV-Cys-HA hydrogels was characterized
by SEM (Figure 1.10). The cross-section SEM images of the TMV-Cys-HA hydrogels
revealed 20–100 μm range of pore size with high porosity and interconnectivity.
Furthermore, a thin layer of compacted outer edge was observed in the cross-section of the
hydrogels. HA hydrogels obtained a similar pore architecture but less porosity and
interconnectivity with a thicker layer of compacted outer edge. The exterior surfaces of
both hydrogels were a dense, rough, and folded architecture with submicron-sized pores
(<2 μm). High degrees of porosity and pore interconnectivity played a critical role in initial
cells or substances penetration, uniform cells distribution, further cell–cell interactions,
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mass transfer of nutrients and metabolites, and tissue growth.44,45 For example, scaffolds
with large pore sizes of 115–335 μm were appropriate for the cartilaginous tissue
formation.44,46 Meanwhile, small pore sizes may help maintain chondrocyte phenotypes,
since chondrocytes are more likely to differentiate when the pore size is about 30 times the
cell diameter, which is approximately 10–15 μm.45

Figure 1.10. Cross-section and surface SEM micrographs of the TMV-based HA hydrogel
after freeze-drying. Scale bar is 200 μm for all images.
1.2.3 Permeability of TMV-Based HA Hydrogels
The permeability of the hydrogels was observed by the fluorescent dye retention
study. The amount of dye diffused into the pre-saturated hydrogel was calculated from the
reduction of fluorescent dye amount measured from fluorescence intensity differences of
the medium over time. Figure 1.11A showed that both hydrogels could absorb the dye in a
similar manner, reaching equilibrium within 1 h. At the equilibrium, the TMV-Cys-HA
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hydrogels accommodated slightly more dye (∼3.3 μg/mL) than the value calculated for the
HA hydrogels (∼2.2 μg/mL). The swelling ratios revealed the ability of the hydrogels to
absorb water. As shown in Figure 1.11B, the swelling ratio of the TMV-Cys-HA hydrogel
was slightly higher than the control HA hydrogel at early time points and became
insignificantly different at later time points. Both hydrogels could absorb water up to 3.5fold of their initial weight. No weight loss in both hydrogels was observed within 21 days
in PBS (Figure 1.11C). We additionally observed a significantly lower mechanical strength
in the TMV-Cys-HA hydrogels compared to the HA hydrogels. The differences in
permeability, swelling rate, and mechanical strength between these two hydrogels could
possibly be attributed to the higher porosity and pore interconnectivity of the TMV-CysHA hydrogels. Karande et al. have reviewed that when the pores are highly interconnected,
an increase in porosity leads to an increase in permeability.47 Furthermore, many studies
have shown that increased porosity and interconnectivity of the hydrogels could improve
the swelling rate of the hydrogels because of enlarging the contact area between the
hydrogels and fluid.48-50 In addition, the increased porosity and interconnectivity of the
hydrogels may lead to a reduction in the solid content of the hydrogels, resulting in a lower
storage modulus.51 In our case, the swelling ratio of both TMV-Cys-HA and HA hydrogels
were insignificantly different at later time points, absorbing water up to 3.5-fold their initial
weight, indicating that both hydrogels exhibited the extreme hydrophilic properties similar
to tissue environment and the capability to uptake medium for cell culture. From the
stability test, no weight loss was observed from both hydrogels during 21 days, indicating
that they could support the entire cell culture experiments and were suitable for tissue
engineering applications.
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Figure 1.11. (A) Permeability of the hydrogels in terms of molecular retention using dye
retention study. (B) Swelling ratios of the hydrogels after gelation and immersion into PBS.
The weight change due to water absorption was monitored over time. (C) The stability of
the hydrogels. The weight loss was observed over time. The values expressed are means ±
SD, n = 3.
1.2.4 Gelation Time of TMV-Based HA Hydrogels
The gelation time is another crucial factor for the development of injectable
hydrogels in terms of therapeutic applications. In the study, the gelation time of the
hydrogels was determined by observing the solution–gel phase transition. We found that
the solution–gel phase transition in the TMV-Cys-HA hydrogels appeared much earlier
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than that in the HA hydrogels. The average gelation time of the TMV-Cys-HA and HA
hydrogels were 15 min and 2 h, respectively (Figure 1.12). It is possible that prior the
addition of DTT, TMV1cys cross-linked to the methacrylated HA backbone via Michael
addition reaction, helping to increase the rate of hydrogel formation. However, the gelation
time of the hydrogels also relied on the basicity of the medium.52,53 We observed that when
primary media or PBS buffer was used and the pH was set to 7.3 and 8, the gelation time
of the HA hydrogels was an average within 6 and 2 h, respectively. This is consistent to
the study by Pritchard et al. showing that the gelation time of thiol–acrylate poly(ethylene
glycol) hydrogels followed an exponential dependence on pH of buffer.53

Figure 1.12. (A) Gelation behavior of the hydrogels was observed via oscillation time
sweep at 25 °C, 2% strain and 10 rad/s frequency. (B) The average gelation time of the
hydrogels. The horizontal bars are means ± SD with each data expressed in dot plots (n =
3); *p < 0.05.
1.2.5 Biocompatibility of TMV-Based HA Hydrogels
The cytotoxicity of the hydrogels was examined by CellTiter-Blue (CTB) cell
viability assay (Figure 1.13). The metabolic rate was normalized by BMSCs encapsulated
in the hydrogels after 1 day. Both hydrogels could support cell viability over 21 days of
culture. The metabolic rate of viable cells in the TMV-Cys-HA hydrogels slightly
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decreased from day 1 to day 7, and slightly increased at later time points. In contrast, the
metabolic rate of viable cells in the HA hydrogels slightly increased from day 1 to day 14,
and slightly decreased at later stage. A possible explanation is that the TMV incorporated
HA hydrogels played a role in cellular differentiation which could occur slowly even
without chondrogenic induction supplements, resulting in a slower metabolic rate of the
cells in early culture days.13

Figure 1.13. Metabolic activity of BMSCs encapsulated in the hydrogels after 1, 7, 14, and
21 days of culturing in complete primary media. The values expressed are means ± SD, n =
3 with two repeated experiments. *Paired equal variance Student t test, p < 0.05.
1.3 CONCLUSIONS
In situ TMV-based HA hydrogels were successfully prepared via Michael addition
reaction under physiological condition. The resulting hydrogels obtained macropore
structures enabling an exchange of nutrients and other biochemical cues. The gelation time
was improved after addition of TMV1cys. The hydrogel was compatible for BMSCs
culture. This study is considered to be a foundation of the development of injectable
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hydrogels incorporated with TMV particles which is applicable for cartilage tissue
engineering and regenerative medicine.
1.4 MATERIALS AND METHODS
1.4.1 Modification of HA and Synthesis of TMV-Based HA Hydrogels
MeHA was synthesized following the literature protocols.54,55 Briefly, HA of
molecular weight 47 kDa (Dali) was dissolved at 1 wt % in potassium phosphate buffer,
pH 8, and methacrylic anhydride (Alfa Aesar) of different folds molar excess (relative to
the HA disaccharide repeat unit), as listed in Table 1.1, was added dropwise to the solution
at 0 °C. The pH of the two-phase reaction mixture was adjusted to 8.0 with 5 M NaOH aq.,
and the reaction continued for 24 h at 4 °C with frequent readjustment of the solution pH.
The product was dialyzed against milli-Q water for at least 48 h, followed by centrifugation
to remove the precipitate, which was then flash frozen in liquid nitrogen, and lyophilized,
resulting in powder that was analyzed by degree of modification by 1H NMR.
Table 1.1. Percent degree of methacrylation of different macromer size HA when reacting
with various molar ratio of methacrylic anhydride.
MW of HA

HA monomer: Methacrylic anhydride molar ratio
1:3

1:6

1:10

1:12

47 kDa

~ 10%

~ 40-50%

100%

100%

310 kDa

N/A

~ 30%

N/A

~ 75%

1 MDa

N/A

Not detectable

N/A

N/A

N/A data not available
TMV1cys was created following the literature protocols.40,56 Briefly, the addition
of a single cysteine residue within the TMV coat protein was created by the insertion of a
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TGT codon at the third position within the coat protein open reading frame using a PCRbased mutagenesis procedure. Nicotiana tabacum, cv Xanthi, a systemic TMV host, was
inoculated with infectious RNA transcripts generated from the TMV1cys cDNA clone.
Virus was harvested after 20 days of inoculation and purified according to previously
reported methods.57,58
To form the TMV-based HA hydrogels (hereafter denoted as TMV-Cys-HA),
MeHA polymers with 40–50% degree of modification were dissolved in a phosphate buffer
saline solution (PBS) at 5 wt % concentration, and TMV1cys in potassium phosphate
buffer was added to make a final concentration of 0.1 wt %. A cross-linking agent,
dithiotreitol (DTT), was then added at a molar ratio of thiol/ene = 1:4. For comparison
purposes, the HA hydrogels were also synthesized by the same procedure, except adding
the TMV1cys solution (as shown in Table 1.2).
Table 1.2. Formulation of the TMV-based HA hydrogel and the controlled HA hydrogel.
Formulation

40-50% DM
MeHA

TMV1cys

0.5 M DTT
(molar ratio)

Solvent, pH
system

TMV-Cys-HA

5%

0.1%

4Ene:1SH

PBS, pH 7.4

HA

5%

-

4Ene:1SH

PBS, pH 7.4

1.4.2 Structure Analysis of TMV-Based HA Hydrogels
Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) analysis
was performed on the TMV-Cys-HA hydrogel. The preformed TMV-Cys-HA hydrogel
(100 μL) was digested using 1800 U Hyaluronidase (HAase) in 1 mL of PBS (Type IV–S
from bovine testes, Sigma) for 2 days. The controls included (1) the purified TMV1cys in
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10 mM potassium phosphate buffer, pH 7; and (2) the HA hydrogel without the virus
digested with 900 U HAase in 200 μL of PBS. Each sample was prepared by mixing the
virus (0.5 mg/mL, 1 μL) or digested hydrogels solution (1 μL) with 9 μL of matrix solution
(saturated sinapic acid in 70% acetonitrile, 0.1% trifluoroacetic acid). A total of 1 μL of
the mixture was spotted on a MALDI plate, air-dried, and analyzed by MALDI-TOF mass
spectrometry (Bruker Ultraflex MALDI-TOF/TOF).
Atomic force microscopy (AFM) was performed on the TMV-Cys-HA hydrogels.
After gelation, the hydrogel was spin-coated on the silicon wafer. The hydrogel-coated
wafer was then dried and subjected to AFM imaging. To study the stability of TMV1cys
in the hydrogel, the TMV-Cys-HA hydrogels after keeping more than 6 months were
digested using 1800 U HAase in 1 mL of PBS for 1 day. The digested hydrogel solution
was coated on the silicon wafer, then dried, and subjected to AFM imaging. The TMV1cys
in the hydrogel was characterized by tapping-mode AFM images using a NanoScope IIIA
MultiMode AFM (Veeco). Si tips with a resonance frequency of approximately 300 kHz,
a spring constant of about 40 N m–1, and a scan rate of 1.0 Hz were used.
Environmental scanning electron microscopy (ESEM) images of the TMV-CysHA and HA hydrogels were obtained by VEGA3 TESCAN electron microscope. The
freeze-dried samples were cross-sectioned and mounted on aluminum stubs with carbon
tape. Samples were observed under a low vacuum with 20 kV of electron acceleration and
a 9.95–13.16 mm of working distance.
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1.4.3 Gelation Time Testing
Oscillatory shear rheology was performed using a DHR-3 rheometer (TA
Instruments) with 12 mm diameter parallel-plate geometry and temperature-controlled
Peltier plate. The TMV-Cys-HA and HA hydrogels were cross-linked in situ between the
rheometer plates in a close chamber, protecting hydrogels from dehydration. The
measurement in oscillatory time sweep mode (2% strain amplitude, 10 rad/s) immediately
started after the freshly prepared prehydrogel mixture was loaded on the Peltier plate.
Typically, 200 μL of the hydrogel solution was used with a gap width of 1 mm between
the plates.
1.4.4 Retention Study
After the hydrogels (150 μL) were fabricated by afore mentioned methods, each
hydrogel was soaked into 5 μg/mL fluoresceinamine isomer I (Sigma) in PBS (400 μL).
The amount of dye diffused into the hydrogel was calculated from the left-over dye
detected from the medium. Dye amounts were transformed from fluorescence intensity
measured at 490/520 nm (Ex/Em) by SpectraMax M2Multi-Mode microplate reader
(Molecular Devices). The standard curve was generated from different dye concentrations
in the range of 1–10 μg/mL plotted over fluorescence intensities (Figure 1.14). The
amounts of dye retention were then calculated into concentrations of dye diffused into the
hydrogels, as shown in the following equation:
Diffused dye concentration =

amount of dye in hydrogel (µg)
hydrogel volume (mL)
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Figure 1.14. Fluorescence spectroscopy calibration with linear fitting curve and equation
for quantification of fluorescein amine isomer I.
1.4.5 Swelling Ratio and Stability Analysis
Swelling property of each hydrogel was determined by the final weight divided by
the initial weight of the hydrogel. The initial weights (∼250 mg) of hydrogels were
recorded (μ0). Hydrogels were immersed in 1 mL of PBS at room temperature, and then
the weights after immersion over time were recorded (μt). Surrounding water was drained
and blotted out with Whatman filter paper from hydrogels before weighing. The swelling
ratios were calculated from μt/μ0.
For the stability test, the hydrogels (250 μL) were incubated with 1 mL of PBS at
room temperature. The hydrogel mass reduction at each time point was monitored. The
hydrogels were collected and lyophilized for at least 24 h before the dry weight was
measured. The dry weight at the starting point was measured as γ0 (∼16 mg). The dry
weight measured at different time point was symbolized γt. Normalized hydrogel dry
weight was calculated as γt/ γ0.
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1.4.6 Bone Marrow Stem Cells (BMSCs) Isolation and Maintenance
Primary BMSCs were isolated from the bone marrow of young adult 160–180 g
male Sprague–Dawley rats (Charles River Laboratories). The procedures were performed
in accordance with the guidelines for animal experimentation by the Institutional Animal
Care and Use Committee, School of Medicine, University of South Carolina. Cells were
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37 °C in a CO2 incubator with
5% CO2/95% air, and passaged no more than seven times after isolation.
1.4.7 In Situ Cell Encapsulation and Culture
The hydrogels were prepared previously described except that the preparation
occurred under sterile condition and prewarmed complete DMEM media was used to
dissolve the polymer. TMV1cys was filtered to remove any pathogens before mixing. All
other components including 5 M NaOH and 0.2 M DTT in PBS were also filtered with 0.2
μm PES membranes. BMSCs passage 3 or 4 were harvested from the tissue culture plate
after reaching 80% confluency. The cells were then mixed with the mixture of prewarmed
hydrogel in DMEM media at concentration of 106 cells/mL right after addition of DTT.
The cells–hydrogel mixture (150 μL) was then pipetted into each Transwell (Corning) that
was inserted and anchored in a 24-well tissue culture plate and incubated at 37 °C in a
CO2 incubator with 5% CO2/95% air. After 6 h of initial incubation, complete primary
media (800 μL) was added into each well. The media was exchanged every 2 days for the
entire experimental period.
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1.4.8 Cell Viability Assay
CellTiter-Blue (CTB) cell viability assay (Promega) was performed after days 1, 7,
14, and 21 of culturing BMSCs in the hydrogels. The culture media in each well was
replaced by 300 mL of prewarmed media containing 15% CTB and incubated for 20 h at
37 °C and 5% CO2. The media containing CTB without cells was used as negative controls.
The media containing metabolite of CTB was measured for fluorescence intensity at
560/590 nm (Ex/Em) using SpectraMax M2Multi-Mode microplate reader (Molecular
Devices).
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CHAPTER 2
IN VITRO MESENCHYMAL STEM CELL CHONDROGENESIS IN THE
IN SITU HYBRIDIZED ROD-LIKE NANOPARTICLE-HYALURONIC
ACID HYDROGEL1
2.1 INTRODUCTION
As mentioned earlier, driving MSC differentiation to the cartilage phenotype in a
3D scaffold is highly challenge to accomplish the cartilage repair by tissue engineering.
Various factors, including growth factor supplement, cell–matrix interaction, hypoxia, and
mechanical stimulus, have been emphasized as important cues promoting MSC
chondrogenesis.1,2 Particularly, the impacts of the ECM topography and biochemical cue
on stem cell fate have been widely studied. The stem cell-ECM interaction in vivo
encompasses the structural components in nanometer length scales, which in turn regulate
stem cell fate along with other physical factors.3-6 Namely, in vivo ECM is composed of
hierarchical fibrils that consist of filamentous proteins, such as collagen, elastin,
fibronectin, vitronectin, and laminin, presenting adhesive ligands on the structures in
spatial organizations and nanoscale dimensions.7 The surface nanotopography of ECM
fibrils plays as a physical cue that can control stem cell behaviors.8 That is, the cell
membrane is augmented with adhesive molecules and protrusive structures in nanoscale

1

Portions of this chapter were adapted from Maturavongsadit, P.; Luckanagul, J. A.; Metavarayuth, K.; Zhao,
X.; Chen, L.; Lin, Y.; Wang, Q. Biomacromolecules 2016, 17, 1930-1938., with permission of publisher
(Appendix A). Copyright (2016) American Chemical Society.
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dimensions that function in cellular probing of extracellular nanotopographical features.
The cellular probing through nanoscale cell-ECM interaction initiates downstream
intracellular mechanotransductive events, leading to cellular behaviors, including cell
adhesion, morphology, proliferation, gene expression, and particular differentiation.9-11
Nanoscale topographical surface and its effect on MSC chondrogenesis have been
previously reported.12-14 However, the results shown have been varying and the topography
was studied only on 2D materials. It is important to investigate how specific
nanotopographies provided in 3D scaffolds regulate the MSC chondrogenesis.
Another challenge to cartilage tissue engineering with MSCs is how to regulate the
differentiation progression. The chondrocytes may be further pushed to hypertrophy,
matrix mineralization, and ossification, also known as terminal differentiation,15-17 lead to
osteophyte or bone formation18 instead of permanent cartilage. To date, it has been debated
whether chondrogenically differentiated MSCs are programmed to progress towards
terminal differentiation and bone formation.16,19 Age-related changes in the ECM
molecules or activation by inflammatory cytokines are believed to play a role in the
progress of terminal differentiation.20-22 Nevertheless, the exact activation mechanism of
chondrocytes into osteophytes is not clearly understood. Type X collagen and MMP13 are
the most widely used markers for chondrocyte hypertrophy.23-25 There are also many genes
and proteins have been shown to be associated with chondrocyte hypertrophy, such as
osteopontin, osteocalcin, Indian Hedgehog, Runx2, VEGF, transglutaminase-2 and
alkaline phosphatase.26-30 The chondrocyte hypertrophy is ultimately developed to calcium
deposition, which appears to be associated with elevated expression of hypertrophy
markers.31
32

In previous chapter, TMV1cys was selected to incorporate in 3D scaffold materials
due to providing nanoscale surface topography, attachment sites for backbone polymers,
high stability, and uniformity. We showed a simple method of modification and
functionalization of HA scaffold materials with TMV1cys by cross-linking method.
Herein, we expected that the covalent incorporation of TMV in 3D hydrogels could support
and accelerate chondrogenesis of MSCs. Various types of rod-like nanoparticles, including
arginine-glycine-aspartic acid (RGD)-mutant TMV (TMV-RGD1), and gold nanorods
(GNRs), were further introduced into the HA-based hydrogels in similar manner to
TMV1cys in order to understand the impact of biochemistry and nanoscale topography
displayed by rod-like nanoparticles in 3D scaffold materials on MSC chondrogenesis.
TMV-RGD1 is TMV that genetically modified to display spatial RGD motifs, cell adhesive
sequences, on the surface structure. The GNRs in this study were synthesized to provide
similar dimensions to TMV (300 nm of length and 20 nm of diameter) except no surface
nanotopographical features. We hypothesized that nanoscale topography and biochemistry
displayed by rod-like nanoparticles synergistically promoted chondrogenesis and inhibited
hypertrophy, matrix mineralization, and ossification of in vitro encapsulated MSCs.
2.2 RESULTS AND DISCUSSION
2.2.1 Effect of the In Situ TMV1cys-Based HA Hydrogels on In Vitro Chondrogenesis of
MSCs
TMV, providing nano-topographic surface in the spatial organizations, has been
used as an effective scaffolding material that could accelerate bone differentiation of
BMSCs in 2D and 3D scaffold materials based on our previous works.32,33 It could
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upregulate the BMP-2 gene expression of the cells on 2D materials within 8 h and promote
alkaline phosphatase activity and calcium phosphate deposition around the cells in 3D
alginate scaffold on day 3 and 6, respectively.32 One possible interpretation of this study is
that the topographical features on TMV play an important role in the accelerated osteogenic
differentiation. Cartilage and bone differentiation of stem cells have shown some common
potent induction proteins, such as BMP-2, BMP-6, and BMP-7.34 The result from several
studies indicated that BMP-2 was an effective inducer of mesenchymal stem cell
differentiation toward chondrocytes.35,36 It regulates chondrogenic development of
mesenchymal progenitors,37 and stimulates the synthesis of chondrocyte matrix
components by human articular chondrocytes in vitro.38,39 In this regard, the development
of 3D scaffold materials with TMV was considered to determine enhanced chondrogenesis
events of BMSCs.
We firstly investigated the BMP-2 gene expression, which is an indication of early
stage chondrogenesis, in the hydrogels after 8 h, 2, and 7 days of chondrogenic culture
(Figure 2.1). Gene expression was normalized by BMSCs before encapsulation, and
GAPDH was used as a housekeeping gene. BMP-2 was expressed at significantly higher
levels in BMSCs encapsulated in the TMV1cys-crosslinked HA hydrogels (hereafter
denoted as TMV-Cys-HA) compared to BMSCs encapsulated in the HA hydrogels after 8
h and 7 days. This result agrees with our previous studies by culturing BMSCs on the TMVbased 2D scaffolds. However, at day 2, no significantly higher level of BMP-2 expression
was observed for BMSCs in the TMV-Cys-HA hydrogels compared to the HA hydrogels.
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Figure 2.1. RT-qPCR analysis of BMP-2 expression in the BMSCs encapsulated in the
hydrogels under chondrogenic conditions for 8 h, 2, and 7 days. The values expressed are
means ± SEM, n = 3 with three repeated experiments. *Paired equal variance
Student t test, p < 0.05.
Immunohistostaining analysis for type II collagen, which is a later-stage
chondrogenic marker, demonstrated significant differences between the TMV-Cys-HA
hydrogels and HA hydrogels over time (14, 21, and 28 days). The differentiated BMSCs
encapsulated in the TMV-Cys-HA hydrogels produced concentrated and well-defined
chondrogenic extracellular matrix (ECM) in the periphery of the cells as indicated by
staining with type II collagen antibody. Especially, after 28 days of culturing, the cells
encapsulated in the TMV-Cys-HA constructs produced a strong type II collagen network
throughout the hydrogels (Figure 2.2A, C). Sirius-Red staining demonstrated the
accumulation of all types and species of collagen present in chondrogenic ECM. In the
TMV-Cys-HA hydrogels, the stain was primarily distributed inside and around BMSCs in
the samples, and was significantly higher than the stain in the HA hydrogels after 28 days
of culture (Figure 2.2B, D). The nondifferentiated BMSCs encapsulated in the TMV-Cys-
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HA and HA hydrogels at day 0 were used as a negative control which showed no existence
of type II collagen and total collagen (Figure 2.2A, B).
The biomechanical property of the BMSCs encapsulated hydrogels was accessed
using rheological analysis. The linear equilibrium modulus plateau (Ge) of the hydrogels
was calculated from the average of storage modulus (G′) over frequency ranging from 0.1
to 10 rad/s at constant strain amplitude of 2%. At day 0, the Ge in the TMV-Cys-HA
hydrogels was significantly lower than that in the HA hydrogels. The average Ge of the
TMV-Cys-HA and HA hydrogels were 59 and 66 Pa, respectively. Both hydrogels showed
a trend of increasing the Ge over 28 days as compared with day 0, 14), indicating that cellsecreted ECM might contribute to the increase in the mechanical property of the hydrogels.
A significant increase in the Ge was observed in the TMV-Cys-HA hydrogels compared to
the HA hydrogels. Notably, the Ge for the TMV-Cys-HA scaffolds doubled, whereas
the Ge for the HA scaffolds increased by 1.3-folds after 28 days of culture (Figure 2.2E).
Combined with the results of collagen accumulation, it indicated that the increase in the
mechanical property of the hydrogels might be contributed by cell-secreted ECM. One
possible mechanism behind the enhanced chondrogenesis event of BMSCs in the TMVbased HA hydrogels likely involves the increase in the level of BMP-2 in the scaffold as a
result of the interactions between the cells and TMV nanoparticles.
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Figure 2.2. The results of in vitro chondrogenesis of MSCs in the in situ TMV1cys-based
HA hydrogels. (A) Confocal images of nondifferentiated and differentiated BMSCs in the
hydrogels under chondrogenic conditions stained for nucleus (blue) and type II collagen
(red) after 0, 14, 21, and 28 days. All images share the same scale bar: 50 μm. (B)
Histochemical staining for total collagen content of nondifferentiated and differentiated
BMSCs in the hydrogels under chondrogenic conditions after 0 day, 14, 21, and 28 days.
All images share the same scale bar: 50 μm. (C, D) Quantification of the signal intensities
of type II collagen and total collagen shown in A and B, respectively. The intensity of type
II collagen and total collagen were normalized to the intensity of nucleus signal and noncollagenous protein signal, respectively. Each plot expressed mean ± SEM, n = 3 with two
repeated experiments. *Paired equal variance Student t test, p < 0.05. (E) Biomechanical
properties of the BMSCs encapsulated hydrogels after 0, 14, and 28 days in chondrogenic
conditions. Each plot expressed mean ± SEM, n = 3 with two repeated experiments.
*Paired equal variance Student’s t test, p < 0.05.
2.2.2 Effect of the In Situ TMV-RGD1-Based HA Hydrogels on In Vitro Chondrogenesis
of MSCs
The effect of biochemical cues provided by TMV in the in situ HA hydrogels on
MSC chondrogenesis was further investigated in this study. Previously, we have
demonstrated that the incorporated biochemical cues to TMV surfaces could alter cell
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responses.40,41 For instance, TMV chemically modified RGD peptide as a 2D TMV-based
material showed increased cell binding capacity, further promoted the proliferation and
osteogenic differentiation of BMSCs. It was possible that RGD ligand spacing on the
surface of TMV was appropriated, 2–4 nm, to offer a polyvalent ligand clustering effect
for enhanced cell receptor signaling.41 Additionally, the coupling of biochemical cues to
scaffold polymers was shown to promote cell responses. Poly(amidoamine) (PAMAM)
dendrimers modified with bioactive molecules, such as RGD, Tyr-Ile-Gly-Ser-Arg
(YIGSR), and Ile-Lys-Val-Ala-Val (IKVAV), as coating polymeric materials
demonstrated increased cell viability, cell adhesion, and enhanced neuron differentiation
of adrenal pheochromocytoma (PC12) cells.42 Based on these studies, we sought to
incorporate TMV-RGD1, concentration of 0.1% w/v, into in situ TMV-Cys-HA to form
the new in situ TMV-hybridized HA hydrogels (hereafter denoted as TMV-Cys-RGD-HA)
that could further alter MSC chondrogenesis. The TMV-Cys-HA at TMV1cys
concentration of 0.2% w/v (hereafter denoted as 2X TMV-Cys-HA) was also generated for
comparison purpose (the formulations in this study are shown in Table 2.1). The
performance of MSC chondrogenesis in these hydrogels was investigated through the
accumulation of type II collagen and total collagen, and the mechanical properties.
Table 2.1. Formulation of HA, TMV1cys-based HA, and TMV-RGD1-based HA
hydrogels.
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The analysis of total collagen revealed that the accumulation of collagen in TMVCys-RGD-HA was significantly higher than those in HA, TMV-Cys-HA and 2X TMVCys-HA after 28 days of culture (Figure 2.3A, B), and no significant enhancement of total
collagen deposition was observed in 2X TMV-Cys-HA compare to TMV-Cys-HA. The
accumulation of type II collagen in these hydrogels showed significantly different after 14
days of culture; that is, TMV-Cys-RGD-HA and 2X TMV-Cys-HA could significantly
promote the type II collagen deposition higher than HA and TMV-Cys-HA. At later time
points, TMV-Cys-HA and 2X TMV-Cys-HA however showed no significantly difference
in promotion of MSC chondrogenesis. Meanwhile, TMV-Cys-RGD-HA showed most
significant enhancement of the accumulation throughout the culturing time (Figure 2.3C,
D). Correspondingly, the mechanical property of TMV-Cys-RGD-HA at day 28 showed
dramatical increase 5 times from day 0, and significantly higher than other hydrogels,
approximately 2.5, 2 and 0.5 times of HA, TMV-Cys-HA, and 2X TMV-Cys-HA,
respectively (Figure 2.3E). Based on this finding, it indicated that TMV-RGD1 could
synergistically promote MSC chondrogenesis in TMV-Cys-HA better than purely
TMV1cys.
The results of TMV-RGD1 in synergistic promotion of MSC chondrogenesis are
agreement to many other research groups’ reports, which have similarly shown that the
incorporated RGD ligands could enhance MSC chondrogenesis. For example, PEG
hydrogels modified with RGD ligands demonstrated increased viability and enhanced
cartilage specific gene expression and matrix synthesis in the presence of mechanical
stimulation.43 It was also found that combination of cartilaginous ECM molecules to the
3D polymer scaffolds could regulate MSC chondrogenesis.44-46 The conjugation of type I
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collagen in PEG scaffolds helped to maintain chondrogenic phenotype and promote
cartilage repair.43 Varying ratios of PEG polymer incorporating to ECM molecules,
including HA, and chondroitin sulfate, could produce different quantities of proteoglycan
and collagen type II deposition mimic the different zones of native articular cartilage.46

Figure 2.3. The results of in vitro chondrogenesis of MSCs in the in situ TMV-RGD1based HA hydrogels compared to the in situ TMV1cys-based HA hydrogels. (A)
Histochemical staining for total collagen content of differentiated BMSCs in the hydrogels
under chondrogenic conditions after 14, 21, and 28 days. All images share the same scale
bar: 50 μm. (B) Quantification of the signal intensities of total collagen shown in A. The
intensity of total collagen was normalized to the intensity of non-collagenous protein
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signal. Each plot expressed mean ± SEM, n = 3 with one repeated experiments. (C)
Confocal images of differentiated BMSCs in the hydrogels under chondrogenic conditions
stained for nucleus (blue) and type II collagen (red) after 14, 21, and 28 days. All images
share the same scale bar: 50 μm (D) Quantification of the signal intensities of type II
collagen shown in C. The intensity of type II collagen was normalized to the intensity of
nucleus signal Each plot expressed mean ± SEM, n = 3. (E) Biomechanical properties of
the BMSCs encapsulated hydrogels after 0, 14, and 28 days in chondrogenic conditions.
Each plot expressed mean ± SEM, n = 3 with one repeated experiments. Statistics:
ANOVA with Tukey’s multiple comparisons tests, *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001.
2.2.3 Effect of the In Situ GNR-Based HA Hydrogels on In Vitro Chondrogenesis of
MSCs
We have confirmed that the rod-like TMV bionanoparticles play a critical role in
directing MSC chondrogenesis in 3D scaffolds, and we hypothesized that the phenomenon
was initially through the interaction of MSCs to spatial-controlled nanotopography offered
by the surface of TMV, which mimic the native extracellular matrix proteins. However, it
may be possible that the promotion is originated by the symmetry of rod-like structures
that help to support the differentiation of MSCs. In this way, we sought to create the similar
rod-like structure to TMV, but lacked the spatial controlled surface nanotopography. GNRs
were selected as the mimicked rod-like TMV, and incorporated into the in situ HA-based
hydrogels to study the MSC chondrogenesis performance.
2.2.3.1 Formation of the In Situ GNR-Based HA Hydrogels
GNRs were first synthesized to obtain the mimicking dimension of TMV. Based
on the characterization by transmission electron microscopy (TEM), GNRs showed the
length of 300-400 nm and the width of 18-20 nm which are similar to the previous protocol
report47 and the TMV structure as expected (as shown in Figure 2.4). The
cetyltrimethylammonium bromide (CTAB), a surface stabilizer of GNRs,47,48 required to
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be removed before using due to interruption of hydrogel formation. After removing the
CTAB by centrifugation at 6000 rpm and replacing with fresh PBS for several times, the
surface of synthesized GNRs was then treated with DTT, thiol molecules, to inhibit the
aggregation of GNR particles. The excess of DTT must be removed and washed for several
times to avoid unwanted DTT react to MeHA during hydrogel formation step. The in situ
GNR-based HA hydrogels (here after denoted as GNR-HA) were then formulated in the
same manner to previous mentioned. It should be noted that there was no expected thiolene “click” reaction occurring between GNRs and MeHA. Hence, the in situ wide-type
TMV-based HA hydrogels (denoted as TMV-HA) were formulated and used as
comparison purpose. HA hydrogels were also generated and used as the controls (Table
2.2).

Figure 2.4. Transmission electron micrograph of wide-type TMVs (A) and GNRs (B).
Table 2.2. Formulation of HA, wide-type TMV-based HA, and GNR-based HA hydrogels.

* The amount of GNRs was calculated based on ICP-MS results.
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2.2.3.2 Physical Properties of the In Situ GNR-Based HA Hydrogels
Before moving forward to in vitro study, it is important to determine how GNRs
impact on the physical properties of HA hydrogels which are crucial for MSC survival and
responses. The microstructure of GNR-HA was determined by SEM images and compared
to TMV-HA and HA systems (Figure 2.5A). The similarities in porosity, and
interconnectivity were observed in all hydrogels. That is, they showed high density of
macropores which were well-interconnected with thin layers of compacted outer edge.
However, they were some differences in ranges of pore size. TMV-HA and GNR-HA
showed a similar range of pore sizes from 100-150 µm, while the HA hydrogels showed a
wider range of pore size from 50-150 µm. The exterior surfaces of all hydrogels were
rough, folded, and dense. The mechanical properties of these hydrogels were also
investigated using DHR-3 Rheometer (Figure 2.5B). Incorporation of GNR in HA
hydrogels showed no impact to complex modulus of the HA hydrogels, which were
approximately 3000 Pa. However, incorporation of TMV-wt into HA scaffolds lead to the
lower complex modulus (1800 Pa), which was similar to the mechanical property results
observed in TMV-Cys-HA (data was not shown). Bovine serum albumin (BSA) protein
was selected as a protein model to assess the diffusibility of the hydrogels. We found that
the BSA diffusibility of in GNR-HA was not significantly different compared to HA
hydrogels, while the BSA diffusibility in TMV-HA was significantly higher than it in HA
hydrogels (Figure 2.5C). Moreover, we observed that all hydrogels had water content more
than 90%, and showed high swelling ratio. The statistically lower swelling ratio was
observed for GNR-HA compared to TMV-HA hydrogels (Figure 2.5D, E). Taken together,
we can see that the incorporation of GNRs into HA hydrogels provided no significant
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impact to the overall physical properties contrast to the incorporation of TMV-wt and its
mutants (the results are shown in previous chapter).

Figure 2.5. Physical properties of the in situ GNR-based HA hydrogels compared to HA
and TMV-based HA hydrogels. (A) Exterior and cross-section SEM micrographs of the in
situ HA, TMV-based HA, and GNR-based HA hydrogels after freeze-drying. Scale bars
for all images: 100 μm. (B) Average complex modulus of the hydrogels after gelation for
2 days (n = 3). (C) BSA release profile of the hydrogels showing the cumulative amount
of BSA released from the hydrogels to supernatant for 24 h (n = 3). Statistics: ANOVA
with Tukey’s multiple comparisons tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001. (D) Water content of the hydrogels after being immersed in PBS for 2 days. (E)
Volumetric-based swelling ratio of the hydrogels (n = 4). Statistics: ANOVA with Tukey’s
multiple comparisons tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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2.2.3.3 In Vitro MSC chondrogenesis in the In Situ GNR-Based HA Hydrogels
For application in MSC chondrogenesis, the biocompatibility of GNR-HA was
validated using CellTiter-Blue (CTB) cell viability assay, fluorometric method measuring
the metabolic capacity of cells (Figure 2.6). After culturing in primary media for 7 days, it
demonstrated that more than 70 % of MSCs were viable in GNR-HA similar to in HA,
TMV-HA. Nevertheless, the compromised viability of the encapsulated cells was occurred
during first few days in 3D scaffolds due to less of oxygen and nutrients compared to that
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in 2D culture.49
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Figure 2.6. Celltiter-Blue assay of viable MSCs encapsulated in the hydrogels after 7 days
of culturing in primary media (n = 3). Statistics: ANOVA with Tukey’s multiple
comparisons tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
The chondrogenesis performance of differentiated MSCs in the GNR-HA was
evaluated by measuring collagen accumulation (total collagen and type II collagen) and
mechanical property of the cell-encapsulated hydrogels. We found that it was very difficult
to quantify collagen accumulation using immunohistological staining of the GNR-HA
hydrogel-embedded paraffin sections. That is, unlike other hydrogels, the cell-encapsulated
GNR-HA hydrogels became pink and very brittle after paraffin embedding, resulting in a
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failure to section the hydrogels. The cryo-sectioning technique can be an alternative for the
in vitro GNR-HA, however, it was not accessed in this study. The mechanical property of
the cell-encapsulated GNR-HA was further measured after 28 days of chondrogenic
cultures. No significantly promoted complex modulus was observed in the cellencapsulated GNR-HA compared to that in the cell-encapsulated HA hydrogels. In
contrast, the average complex modulus of the in vitro TMV-HA hydrogels showed
significantly higher than that in GNR-HA (Figure 2.7A).
The impact of incorporated GNRs in HA-based scaffolds on chondrogenic
differentiation progression was also investigated. As described earlier that the
chondrogenic-differentiated MSCs are possible to develop to unwanted hypertrophy stage,
the alkaline phosphatase (ALP) activity and calcium deposition, common hypertrophy
markers, were quantified in the hydrogels after 28 days. The results of ALP activities
demonstrated that the differentiated MSCs in GNR-HA and HA hydrogels secreted ALP
significantly higher than that in TMV-HA (Figure 2.7B). Although calcium deposition was
hardly quantified in all the hydrogels due to the background color, it slightly showed the
calcium deposited spots spread out throughout in the matrix of GNR-HA and HA samples,
but not in TMV-HA (Figure 2.7C).
Based on these results, it seems to us that GNRs incorporated HA hydrogels did not
promote the MSC chondrogenesis, contrast to the results observed in TMV-incorporated
or TMV-crosslinked HA hydrogels. It is possible that the surface of GNRs is covered with
DTT providing no any special surface nanotopography. Conversely, the TMV surface
displays 2,130 identical coat proteins in the spatial organization which could offer the cell
surface interaction and protein absorption. However, in this study, to firmly conclude the
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impact of nanoscale surface topography by TMV compared to similar rod-like
nanostructure, i.e. GNRs, in 3D scaffolds on MSC chondrogenesis, several experiments
should be further evaluated, such as type II, I, X collagen and chondroitin sulfate
accumulation.

Figure 2.7. The results of in vitro chondrogenesis of MSCs in the in situ GNR-based HA
hydrogels compared to the in situ HA and TMV-based HA hydrogels. (A) Biomechanical
properties of the differentiated MSCs hydrogels after 28 days in chondrogenic conditions.
Each plot expressed mean ± SEM, n = 3. (B) Quantification of the signal intensities of
calcium deposition of differentiated MSCs in the hydrogels under chondrogenic conditions
after 28 days. The intensity of calcium in each sample was normalized to the intensity of
calcium signal in negative control (HA hydrogel without cells). Each plot expressed mean
± SEM, n = 3 with one repeated experiments. (C) ALP activities of differentiated MSCs in
the hydrogels under chondrogenic conditions after 28 days. ALP activities were performed
by pnitrophenyl phosphate assay. Each plot expressed mean ± SEM, n = 6. (D) CelltiterBlue assay of viable differentiated MSCs encapsulated in the hydrogels after 28 days in
chondrogenic conditions. The viability of each sample was normalized to the viability of
cells in HA. Each plot expressed mean ± SEM, n = 6. Statistics: ANOVA with Tukey’s
multiple comparisons tests, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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2.3 CONCLUSIONS
In situ TMV-based HA hydrogels supported significantly greater chondrogenesis
in terms of compositions and biomechanical properties compared to the HA hydrogels. The
introduction of other rod-like nanoparticles into HA hydrogels was also studied which aims
for understanding the role of topographical features of nanoparticles in chondrogenesis
process. The incorporation of TMV-RGD1 in HA hydrogels further promoted in vitro
chondrogenesis of BMSCs. Meanwhile, the incorporation of gold nanorods, which provide
similar size and shape to TMV, in HA hydrogels seemed likely to no promotion of the in
vitro chondrogenesis. This implied that the influences of nanoscale topography and
biochemistry provided by TMV and TMV-RGD1 play critical roles in directing
encapsulated MSC chondrogenesis. Currently, the in vivo studies have been conducted to
test the biocompatibility and in vivo cartilage formation using TMV-incorporated
injectable hydrogels.
2.4 MATERIALS AND METHODS
2.4.1 Synthesis of Rod-Like Nanoparticles and Rod-Like Nanoparticle-HA Hydrogels
TMV-wt, TMV1cys and TMV-RGD1 were isolated from infected tobacco leaves
following previously established protocols.50,51 Gold nanorods (GNRs) were synthesized
following previously established protocol.47 After removing the CTAB by centrifugation
at 6000 rpm for several times, The CTAB surfactant-directing agents on surface of
synthesized GNRs were removed by centrifugation at 6000 rpm and replacing with PBS
for several times. The surface of synthesized GNRs was then treated with DTT, thiol
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molecules, for 30 min with stirring. The excess of DTT was removed and washed by
centrifugation at 6000 rpm for several times. The structure integrity of TMV particles and
GNRs were verified by TEM electron micrograph.
To form the rod-like nanoparticles based HA hydrogels (TMV-Cys-HA, 2X TMVCys-HA, TMV-Cys-RGD-HA, TMV-HA and GNR-HA), MeHA polymers with 40–50%
degree of modification were dissolved in a PBS at 5 wt% concentration, and TMV1cys,
TMV-RGD1, TMV-wt, or GNRs in potassium phosphate buffer was added to make a final
concentration of 0.1 or 0.2 wt% (the detailed formulations are in Table 2.1 and 2.2). A
cross-linking agent, dithiotreitol (DTT), was then added at a molar ratio of thiol/ene = 1:4
or 1:2 (Table 2.1 and 2.2). For comparison purposes, the HA hydrogels were also
synthesized by the same procedure, except adding the rod-like nanoparticle solution.
2.4.2 Characterization of GNR-Based HA Hydrogels
2.4.2.1 Microstructure Analysis
Microstructure of the hydrogels was characterized using Scanning Electron
Microscope (SEM). The hydrogel samples were lyophilized, then cross-sectioned and
mounted on metal stubs with carbon tape. The samples were sputtered coated with
gold/palladium for 30 sec on a Denton Desk II sputter coater with global rotation and tilt.
The surfaces of the gold/palladium-coated hydrogels samples were observed at 5-8 random
locations per sample (n = 3) on a Zeiss Ultraplus Thermal Field Emission SEM at 10 kV.
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2.4.2.2 Mechanical Properties
Complex modulus (G*) of the hydrogels was determined using a DHR-3 rheometer
(TA Instruments) with 12 mm diameter parallel-plate geometry at 25 °C. The hydrogels
were prepared previously described by using PBS as the medium. After gelation for 2 days,
the samples were prepared and tested following our previous protocol.52
2.4.2.3 Swelling Properties
The hydrogels (50 μL) were prepared previously described by using PBS as the
medium. After gelation, the hydrogels were swollen in PBS for 2 days and were then
blotted to remove excess water and weighed to obtain the swollen hydrogel mass (Ms). The
dry mass of these hydrogels (Md) was then determined after drying by the lyophilization
method. Water content, the mass-based swelling ratio (Qm), and the volumetric-based
swelling ratios (Qv) were calculated based on the equations reported in the previous
literature.53
2.4.2.4 Protein Release Profile
To study the protein release profile and protein accumulation within the hydrogels,
bovine serum albumin (BSA) was chosen as the model solute for diffusion. The
experimental procedure was adapted from the literature.54 Briefly, the hydrogels (2 mm
thickness, 4 mm diameter) were immersed in BSA solution (1 mg/mL) at room temperature
for 30 h to achieve uniform protein loading.54,55 After that, all of BSA solution was
removed, and the BSA-loaded hydrogels were immersed in PBS. All supernatant was
collected and replaced by fresh PBS at 5, 10, 15, 30, 45, 60, 90, 120 min, and 24 h. A
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Coomassie (Bradford) protein assay (Thermo Scientific) was used to quantify the amount
of released BSA in the supernatant following the manufacturer’s protocol.
2.4.3 Bone Marrow Stem Cells (BMSCs) Isolation and Maintenance
Primary BMSCs were isolated from the bone marrow of young adult 160–180 g
male Sprague–Dawley rats (Charles River Laboratories). The procedures were performed
in accordance with the guidelines for animal experimentation by the Institutional Animal
Care and Use Committee, School of Medicine, University of South Carolina. Cells were
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37 °C in a CO2 incubator with
5% CO2/95% air, and passaged no more than seven times after isolation.
2.4.4 In Situ Cell Encapsulation and Culture
The hydrogels were prepared previously described except that the preparation
occurred under sterile condition and prewarmed complete DMEM media was used to
dissolve the polymer. TMV1cys, TMV-RGD1, TMV-wt and GNRs were filtered to remove
any pathogens before mixing. All other components including 5 M NaOH and 0.5 M DTT
in PBS were also filtered with 0.2 μm PES membranes. BMSCs passage 3 or 4 were
harvested from the tissue culture plate after reaching 80% confluency. The cells were then
mixed with the mixture of prewarmed hydrogel in DMEM media at concentration of
106cells/mL right after addition of DTT. The cells–hydrogel mixture (150 μL) was then
pipetted into each Transwell (Corning) that was inserted and anchored in a 24-well tissue
culture plate and incubated at 37 °C in a CO2 incubator with 5% CO2/95% air. After 6 h of
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initial incubation, chondrogenic media (800 μL) was added into each well. The media was
exchanged every 2 days for the entire experimental period.
Chondrogenic supplemented media comprised of DMEM (Hyclone, Thermo
scientific), 1% fetal bovine serum (Atlanta biologicals), 1× penicillin-streptomycinamphotericin B (from MP Biomedicals, 100 U/mL penicillin and 1000 U/mL streptomycin
solution, 0.25 μg/mL amphotericin B), 100 nM dexamethasone (Enzo Life Sciences), 10
ng/mL TGF β1 (R&D System), 50 μg/mL ascorbic acid (Sigma-Aldrich), 1 mM sodium
pyruvate (Hyclone, Thermo scientific), 1 × ITS+3(from Sigma-Aldrich, contains 1.0
mg/mL insulin from bovine pancreas, 0.55 mg/mL human transferrin (substantially ironfree), 0.5 μg/mL sodium selenite, 470 μg/mL linoleic acid, 470 μg/mL oleic acid, and 50
mg/mL bovine serum albumin), 2 mM l-glutamine (Hyclone, Thermo scientific), and 40
μg/mL l-proline (Sigma-Aldrich).
2.4.5 BMP-2 Gene Expression Analysis
The hydrogels were harvested and analyzed for BMP-2 gene expression after 8 h,
2 and 7 days in chondrogenic culture. The sample was rinsed twice with PBS buffer and
stabilized in RNAlater solution (protecting RNA from degradation) overnight at 4 °C. The
sample was then lysed by high-speed homogenizer at 20000 rpm in RNAzol (SigmaAldrich) at room temperature for 5 min. The total RNA was extracted according to the
manufacturer’s protocol. Briefly, the quality and quantity of the extracted total RNA were
analyzed using Experion RNA StdSens Analysis Kit (Bio-Rad) and was reverse transcribed
to cDNA using qScript cDNA Synthesis kit (Quanta Biosciences). RT-qPCR (iQ5 realtime PCR detection system Bio-Rad Laboratories) was then performed by the method
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described as 45 cycles of PCR (95 °C for 20 s, 58 °C for 15 s, and 72 °C for 15 s), after
initial denaturation step of 5 min at 95 °C, by using 12.5 μL of iQ5 SYBR Green I Supermix
2 pmol/mL of each forward and reverse primers and 0.5 μL cDNA templates in a final
reaction volume of 25 μL. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
used as the housekeeping gene. Data collection was enabled at 72 °C in each cycle and CT
(threshold cycle) values were calculated using the iQ5 optical system software version 2.1.
The expression levels of differentiated genes and undifferentiated genes were calculated
using Pfaffl’s method for group-wise comparison and statistical analysis of relative
expression results in real-time PCR, using GAPDH as the reference gene. Quantification
of gene expression was based on the CT value of each sample which was calculated as the
average of three replicate measurements for each sample analyzed. The fold change of each
gene expression level is normalized to BMSCs before encapsulation in the hydrogels. The
primers were synthesized commercially (Integrated DNA Technologies, Inc.), and
evaluated at an annealing temperature of 58 °C.
2.4.6 Histological and Immunohistochemical Analysis
The culture samples were fixed in 4% paraformaldehyde for at least 24 h at 4 °C,
dehydrated with a graded ethanol series, and then embedded in paraffin. The sections, 10
μm in thickness, were stained with Sirius Red and Fast Green stain by using Sirius Red/Fast
Green Collagen staining kit (Chondrex, Inc.) for collagen quantification. The samples were
stained according to the manufacturer’s protocol. The stained sections were imaged by a
light microscope (Olympus IX81) under 20× lens.

53

For the immunohistochemical staining of type II collagen, separate sections were
permeabilized with 0.05% Tween20 in Tris-buffered saline solution (TBS) for 15 min and
blocked in 2% BSA in TBS for 20 min. The sections were then incubated with rabbit
anticollagen type II monoclonal antibody (Sigma-Aldrich) at 1:100 dilution in blocking
buffer at room temperature for 2 h. After the samples were washed thrice with TBS, they
were incubated with secondary antibody detection Alexafluor 546 at 1:200 dilution in
blocking buffer at room temperature for 1 h. They were then washed thrice with TBS and
counterstained with DAPI (4,6-diamidino-2-phenylindole, 100 ng/mL) for 15 min. Finally,
the sections were mounted for microscopic observation. Images of the stained sections
were collected using Olympus IX81 epi-flour mode under 20× lens, exposure times 50 ms
for DAPI and 1000 ms for collagen II.
2.4.7 Biomechanical Property Analysis
The hydrogels were collected at days 0, 14, and 28 of chondrogenic culturing and
subjected to test storage (G′) and loss (G′′) moduli using DHR-3 rheometer (TA
Instruments) with 12 mm diameter parallel-plate geometry and temperature controlled
Peltier plate. The samples were cut into uniform cylinders and placed on a metal plate,
where the tests were performed. Amplitude sweeps at constant frequency (1 rad/s) were
performed to determine the linear viscoelastic range of deformation for each sample, after
which frequency sweeps (0.1–10 rad/s) were performed at a strain amplitude within the
linear range (2%). In amplitude and frequency sweeps measurement, the geometry gaps
were conditioned by axial force at 0.5 N for every run. The linear equilibrium modulus
plateau (Ge) of hydrogels was calculated from the average of storage modulus (G′) over the
frequency range.
54

2.4.8 Alkaline Phosphatase (ALP) Activity Test
Alkaline phosphatase (ALP) activity was determined using pNPP (pnitrophenyl
phosphate) assay (Thermo Scientific). After 3, 7 and 28 days of induction in the osteogenic
media, the hydrogels with cells were prewashed with PBS then incubated with pNPP
solution at room temperature for 1 h. Absorbance was read using a M2 SpectraMax plate
reader at 405 nm, indicating ALP activity levels. The enzyme activity was calculated from
Beer−Lambert law as follows,
Enzyme activity (µmol⁄ min⁄ construct) =

V(µL) × OD405 nm (cm-1)
ε ×incubation time (min)× cell

where ε is the molar extinction coefficient (M-1 × cm-1). For pNPP, ε = 1.78 × 104 M-1 ×
cm-1, OD405 nm (cm-1) is the absorbance at 405 nm divided by the light-path length (cm),
and V is the final assay volume.
2.4.9 Histological Staining for Calcium Deposition
Alizarin Red S (ARS) staining for Ca2+ was performed after 28 days of
chondrogenic cultures. The hydrogels with cells were washed three times with PBS, and
were stained with 0.1% solution of ARS (Sigma-Aldrich) pH 4.2 for 30 min, washed with
PBS to remove excess stain. The stained hydrogels were imaged by a light microscope
(Olympus I×81) under 4× lens. Negative control experiments (before induction in the
chondrogenic media) were conducted for all types of the hydrogels.

55

2.5 REFERENCES
(1) Tenney, R. M.; Discher, D. E. Stem Cells, Microenvironment Mechanics, and Growth
Factor Activation. Curr. Opin. Cell Biol. 2009, 21, 630-635.
(2) Harada, T.; Swift, J.; Irianto, J.; Shin, J.-W.; Spinler, K. R.; Athirasala, A.; Diegmiller,
R.; Dingal, P. D. P.; Ivanovska, I. L.; Discher, D. E. Nuclear Lamin Stiffness Is a Barrier
to 3d Migration, but Softness Can Limit Survival. J. Cell Biol. 2014, jcb. 201308029.
(3) Takagi, J.; Petre, B. M.; Walz, T.; Springer, T. A. Global Conformational
Rearrangements in Integrin Extracellular Domains in Outside-in and inside-out Signaling.
Cell 2002, 110, 599-611.
(4) Park, J.; Bauer, S.; von der Mark, K.; Schmuki, P. Nanosize and Vitality: Tio2
Nanotube Diameter Directs Cell Fate. Nano Lett. 2007, 7, 1686-1691.
(5) Crisan, M.; Yap, S.; Casteilla, L.; Chen, C.-W.; Corselli, M.; Park, T. S.; Andriolo, G.;
Sun, B.; Zheng, B.; Zhang, L. A Perivascular Origin for Mesenchymal Stem Cells in
Multiple Human Organs. Cell stem cell 2008, 3, 301-313.
(6) Chen, W.; Shao, Y.; Li, X.; Zhao, G.; Fu, J. Nanotopographical Surfaces for Stem Cell
Fate Control: Engineering Mechanobiology from the Bottom. Nano Today 2014, 9, 759784.
(7) Kim, H. N.; Jiao, A.; Hwang, N. S.; Kim, M. S.; Kang do, H.; Kim, D. H.; Suh, K. Y.
Nanotopography-Guided Tissue Engineering and Regenerative Medicine. Adv Drug Deliv
Rev 2013, 65, 536-558.
(8) Das, R. K.; Zouani, O. F.; Labrugère, C.; Oda, R.; Durrieu, M.-C. Influence of
Nanohelical Shape and Periodicity on Stem Cell Fate. ACS Nano 2013, 7, 3351-3361.

56

(9) Lemischka, I. R.; Moore, K. A. Stem Cells: Interactive Niches. Nature 2003, 425, 778779.
(10) Sun, Y.; Chen, C. S.; Fu, J. Forcing Stem Cells to Behave: A Biophysical Perspective
of the Cellular Microenvironment. Annual review of biophysics 2012, 41, 519-542.
(11) Kim, D.-H.; Provenzano, P. P.; Smith, C. L.; Levchenko, A. Matrix Nanotopography
as a Regulator of Cell Function. The Journal of Cell Biology 2012, 197, 351-360.
(12) Li, W.-J.; Mauck, R. L.; Cooper, J. A.; Yuan, X.; Tuan, R. S. Engineering Controllable
Anisotropy in Electrospun Biodegradable Nanofibrous Scaffolds for Musculoskeletal
Tissue Engineering. J. Biomech. 2007, 40, 1686-1693.
(13) Baker, B. M.; Nathan, A. S.; Gee, A. O.; Mauck, R. L. The Influence of an Aligned
Nanofibrous Topography on Human Mesenchymal Stem Cell Fibrochondrogenesis.
Biomaterials 2010, 31, 6190-6200.
(14) Wu, Y.-N.; Law, J. B. K.; He, A. Y.; Low, H. Y.; Hui, J. H. P.; Lim, C. T.; Yang, Z.;
Lee, E. H. Substrate Topography Determines the Fate of Chondrogenesis from Human
Mesenchymal Stem Cells Resulting in Specific Cartilage Phenotype Formation. Nanomed.
Nanotechnol. Biol. Med. 2014, 10, 1507-1516.
(15) Pacifici, M.; Golden, E. B.; Oshima, O.; Shapiro, I. M.; Leboy, P. S.; Adams, S. L.
Hypertrophic Chondrocytes. The Terminal Stage of Differentiation in the Chondrogenic
Cell Lineage? Ann. N.Y. Acad. Sci. 1990, 599, 45-57.
(16) Pelttari, K.; Winter, A.; Steck, E.; Goetzke, K.; Hennig, T.; Ochs, B. G.; Aigner, T.;
Richter, W. Premature Induction of Hypertrophy During in Vitro Chondrogenesis of
Human Mesenchymal Stem Cells Correlates with Calcification and Vascular Invasion after
Ectopic Transplantation in Scid Mice. Arthritis Rheum. 2006, 54, 3254-3266.

57

(17) Yoo, J. U.; Johnstone, B. The Role of Osteochondral Progenitor Cells in Fracture
Repair. Clin Orthop Relat Res 1998, S73-81.
(18) van der Kraan, P. M.; van den Berg, W. B. Osteophytes: Relevance and Biology.
Osteoarthritis Cartilage 2007, 15, 237-244.
(19) Steinert, A. F.; Ghivizzani, S. C.; Rethwilm, A.; Tuan, R. S.; Evans, C. H.; Nöth, U.
Major Biological Obstacles for Persistent Cell-Based Regeneration of Articular Cartilage.
Arthrit. Res. Ther. 2007, 9, 213.
(20) Goldring, M. B.; Otero, M.; Plumb, D. A.; Dragomir, C.; Favero, M.; El Hachem, K.;
Hashimoto, K.; Roach, H. I.; Olivotto, E.; Borzì, R. M.; Marcu, K. B. Roles of
Inflammatory and Anabolic Cytokines in Cartilage Metabolism: Signals and Multiple
Effectors Converge Upon Mmp-13 Regulation in Osteoarthritis. European cells &
materials 2011, 21, 202-220.
(21) Marcu, K. B.; Otero, M.; Olivotto, E.; Borzi, R. M.; Goldring, M. B. Nf-Κb Signaling:
Multiple Angles to Target Oa. Curr. Drug Targets 2010, 11, 599-613.
(22) Loeser, R. F. Age-Related Changes in the Musculoskeletal System and the
Development of Osteoarthritis. Clin. Geriatr. Med. 2010, 26, 371-386.
(23) Nurminskaya, M.; Linsenmayer, T. F. Identification and Characterization of upRegulated Genes During Chondrocyte Hypertrophy. Dev. Dyn. 1996, 206, 260-271.
(24) Kirsch, T.; von der Mark, K. Remodelling of Collagen Types I, Ii and X and
Calcification of Human Fetal Cartilage. Bone Miner. 1992, 18, 107-117.
(25) Alvarez, J.; Balbin, M.; Santos, F.; Fernandez, M.; Ferrando, S.; Lopez, J. M. Different
Bone Growth Rates Are Associated with Changes in the Expression Pattern of Types Ii

58

and X Collagens and Collagenase 3 in Proximal Growth Plates of the Rat Tibia. J. Bone
Miner. Res. 2000, 15, 82-94.
(26) Binette, F.; McQuaid, D. P.; Haudenschild, D. R.; Yaeger, P. C.; McPherson, J. M.;
Tubo, R. Expression of a Stable Articular Cartilage Phenotype without Evidence of
Hypertrophy by Adult Human Articular Chondrocytes in Vitro. J. Orthop. Res. 1998, 16,
207-216.
(27) Johnson, K. A.; Van Etten, D.; Nanda, N.; Graham, R. M.; Terkeltaub, R. A. Distinct
Transglutaminase 2-Independent and Transglutaminase 2-Dependent Pathways Mediate
Articular Chondrocyte Hypertrophy. J. Biol. Chem. 2003, 278, 18824-18832.
(28) Mueller, M. B.; Tuan, R. S. Functional Characterization of Hypertrophy in
Chondrogenesis of Human Mesenchymal Stem Cells. Arthritis & Rheumatology 2008, 58,
1377-1388.
(29) Solomon, L. A.; Bérubé, N. G.; Beier, F. Transcriptional Regulators of Chondrocyte
Hypertrophy. Birth Defects Res. C. Embryo Today Rev. 2008, 84, 123-130.
(30) Horner, A.; Bishop, N.; Bord, S.; Beeton, C.; Kelsall, A.; Coleman, N.; Compston, J.
Immunolocalisation of Vascular Endothelial Growth Factor (Vegf) in Human Neonatal
Growth Plate Cartilage. The Journal of Anatomy 1999, 194, 519-524.
(31) Fuerst, M.; Bertrand, J.; Lammers, L.; Dreier, R.; Echtermeyer, F.; Nitschke, Y.;
Rutsch, F.; Schafer, F. K.; Niggemeyer, O.; Steinhagen, J.; Lohmann, C. H.; Pap, T.;
Ruther, W. Calcification of Articular Cartilage in Human Osteoarthritis. Arthritis Rheum.
2009, 60, 2694-2703.

59

(32) Sitasuwan, P.; Lee, L. A.; Bo, P.; Davis, E. N.; Lin, Y.; Wang, Q. A Plant Virus
Substrate Induces Early Upregulation of Bmp2 for Rapid Bone Formation. Integrative
biology : quantitative biosciences from nano to macro 2012, 4, 651-660.
(33) Luckanagul, J.; Lee, L. A.; Nguyen, Q. L.; Sitasuwan, P.; Yang, X.; Shazly, T.; Wang,
Q. Porous Alginate Hydrogel Functionalized with Virus as Three-Dimensional Scaffolds
for Bone Differentiation. Biomacromolecules 2012, 13, 3949-3958.
(34) Chubinskaya, S.; Segalite, D.; Pikovsky, D.; Hakimiyan, A. A.; Rueger, D. C. Effects
Induced by Bmps in Cultures of Human Articular Chondrocytes: Comparative Studies.
Growth Factors 2008, 26, 275-283.
(35) Schmitt, B.; Ringe, J.; Haupl, T.; Notter, M.; Manz, R.; Burmester, G. R.; Sittinger,
M.; Kaps, C. Bmp2 Initiates Chondrogenic Lineage Development of Adult Human
Mesenchymal Stem Cells in High-Density Culture. Differentiation 2003, 71, 567-577.
(36) Fischer, L.; Boland, G.; Tuan, R. S. Wnt Signaling During Bmp-2 Stimulation of
Mesenchymal Chondrogenesis. J. Cell. Biochem. 2002, 84, 816-831.
(37) Duprez, D. M.; Coltey, M.; Amthor, H.; Brickell, P. M.; Tickle, C. Bone
Morphogenetic Protein-2 (Bmp-2) Inhibits Muscle Development and Promotes Cartilage
Formation in Chick Limb Bud Cultures. Dev. Biol. 1996, 174, 448-452.
(38) Luyten, F. P.; Yu, Y. M.; Yanagishita, M.; Vukicevic, S.; Hammonds, R. G.; Reddi,
A. H. Natural Bovine Osteogenin and Recombinant Human Bone Morphogenetic Protein2b Are Equipotent in the Maintenance of Proteoglycans in Bovine Articular Cartilage
Explant Cultures. J. Biol. Chem. 1992, 267, 3691-3695.

60

(39) Sailor, L. Z.; Hewick, R. M.; Morris, E. A. Recombinant Human Bone Morphogenetic
Protein-2 Maintains the Articular Chondrocyte Phenotype in Long-Term Culture. J.
Orthop. Res. 1996, 14, 937-945.
(40) Lee, L. A.; Nguyen, Q. L.; Wu, L.; Horvath, G.; Nelson, R. S.; Wang, Q. Mutant Plant
Viruses with Cell Binding Motifs Provide Differential Adhesion Strengths and
Morphologies. Biomacromolecules 2012, 13, 422-431.
(41) Sitasuwan, P.; Lee, L. A.; Li, K.; Nguyen, H. G.; Wang, Q. Rgd-Conjugated Rod-Like
Viral Nanoparticles on 2d Scaffold Improve Bone Differentiation of Mesenchymal Stem
Cells. Frontiers in chemistry 2014, 2, 31.
(42) Maturavongsadit, P.; Bi, X.; Gado, T. A.; Nie, Y.-Z.; Wang, Q. Adhesive Peptides
Conjugated Pamam Dendrimer as a Coating Polymeric Material Enhancing Cell
Responses. Chin. Chem. Lett. 2016, 27, 1473-1478.
(43) Villanueva, I.; Weigel, C. A.; Bryant, S. J. Cell-Matrix Interactions and Dynamic
Mechanical Loading Influence Chondrocyte Gene Expression and Bioactivity in Peg-Rgd
Hydrogels. Acta Biomater. 2009, 5, 2832-2846.
(44) Deponti, D.; Giancamillo, A. D.; Gervaso, F.; Domenicucci, M.; Domeneghini, C.;
Sannino, A.; Peretti, G. M. Collagen Scaffold for Cartilage Tissue Engineering: The
Benefit of Fibrin Glue and the Proper Culture Time in an Infant Cartilage Model. Tissue
Engineering Part A 2013, 20, 1113-1126.
(45) Kawamura, S.; Wakitani, S.; Kimura, T.; Maeda, A.; Caplan, A. I.; Shino, K.; Ochi,
T. Articular Cartilage Repair: Rabbit Experiments with a Collagen Gel-Biomatrix and
Chondrocytes Cultured in It. Acta Orthop. Scand. 1998, 69, 56-62.

61

(46) Nguyen, L. H.; Kudva, A. K.; Guckert, N. L.; Linse, K. D.; Roy, K. Unique
Biomaterial Compositions Direct Bone Marrow Stem Cells into Specific Chondrocytic
Phenotypes Corresponding to the Various Zones of Articular Cartilage. Biomaterials 2011,
32, 1327-1338.
(47) Gole, A.; Murphy, C. J. Seed-Mediated Synthesis of Gold Nanorods: Role of the Size
and Nature of the Seed. Chem. Mater. 2004, 16, 3633-3640.
(48) Nikoobakht, B.; El-Sayed, M. A. Evidence for Bilayer Assembly of Cationic
Surfactants on the Surface of Gold Nanorods. Langmuir 2001, 17, 6368-6374.
(49) Luca, A. C.; Mersch, S.; Deenen, R.; Schmidt, S.; Messner, I.; Schäfer, K.-L.; Baldus,
S. E.; Huckenbeck, W.; Piekorz, R. P.; Knoefel, W. T.; Krieg, A.; Stoecklein, N. H. Impact
of the 3d Microenvironment on Phenotype, Gene Expression, and Egfr Inhibition of
Colorectal Cancer Cell Lines. PLoS One 2013, 8, e59689.
(50) Niu, Z.; Bruckman, M. A.; Li, S.; Lee, L. A.; Lee, B.; Pingali, S. V.; Thiyagarajan, P.;
Wang, Q. Assembly of Tobacco Mosaic Virus into Fibrous and Macroscopic Bundled
Arrays Mediated by Surface Aniline Polymerization. Langmuir 2007, 23, 6719-6724.
(51) Bruckman, M. A.; Kaur, G.; Lee, L. A.; Xie, F.; Sepulveda, J.; Breitenkamp, R.;
Zhang, X.; Joralemon, M.; Russell, T. P.; Emrick, T.; Wang, Q. Surface Modification of
Tobacco Mosaic Virus with "Click" Chemistry. ChemBioChem 2008, 9, 519-523.
(52) Maturavongsadit, P.; Luckanagul, J. A.; Metavarayuth, K.; Zhao, X.; Chen, L.; Lin,
Y.; Wang, Q. Promotion of in Vitro Chondrogenesis of Mesenchymal Stem Cells Using in
Situ Hyaluronic Hydrogel Functionalized with Rod-Like Viral Nanoparticles.
Biomacromolecules 2016, 17, 1930-1938.

62

(53) Wieland, J. A.; Houchin-Ray, T. L.; Shea, L. D. Non-Viral Vector Delivery from PegHyaluronic Acid Hydrogels. J. Controlled Release 2007, 120, 233-241.
(54) Lee, S.; Tong, X.; Yang, F. The Effects of Varying Poly(Ethylene Glycol) Hydrogel
Crosslinking Density and the Crosslinking Mechanism on Protein Accumulation in ThreeDimensional Hydrogels. Acta Biomater. 2014, 10, 4167-4174.
(55) Weber, L. M.; Lopez, C. G.; Anseth, K. S. Effects of Peg Hydrogel Crosslinking
Density on Protein Diffusion and Encapsulated Islet Survival and Function. Journal of
Biomedical Materials Research Part A 2009, 90A, 720-729.

63

CHAPTER 3
THE OPTIMIZATION OF PHYSICAL AND MECHANICAL
PROPERTIES OF THE THIOL–ENE “CLICK” HA HYDROGELS
THROUGH CHEMISTRIES OF CROSS-LINKERS FOR
OSTEOCHONDRAL REGENERATION APPLICATIONS1
3.1 INTRODUCTION
In this chapter, the physical properties of scaffolds, i.e., mechanical stiffness, 1
network porosity,2 permeability,3,4 and degradation rates,5,6 are particularly focused to
develop in order to better support the differentiation of encapsulated MSCs. Especially, the
mechanical properties of the scaffold have attracted greater attention as the role of the
extracellular matrix (ECM) in directing stem cell fate.7-9 The scaffolds for cartilage and
subchondral bone tissue engineering must provide adequate mechanical strength to support
cells and withstand in vivo forces during joint movement. Many studies showed that
chondrogenesis and osteogenesis of MSCs could be promoted in stiff scaffolds,
approximately 1-3 kPa,10,11 and 11-250 kPa,12,13 respectively. With recent advances,
researchers have attempted to enhance the mechanical properties of traditional hydrogels
by many strategies, such as increasing crosslinking density, and addition of multiple
polymers, often including two or more independent networks (Figure 3.1).14 These systems
not only typically achieve stronger mechanical properties than the conventional hydrogels,
1

Portions of this chapter were adapted with permission from Maturavongsadit, P.; Bi, X.; Metavarayuth, K.;
Amie Luckanagul, J.; Wang, Q. ACS Applied Materials and Interfaces 2017, 9 (4), 3318–3329. Copyright
(2017) American Chemical Society (Appendix D).
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but may exhibit superior promotion of tissue formation15,16 and integration with
surrounding tissue in vivo.17-19 Therefore, we sought to develop our in situ forming
hydrogel systems using these strategies, in particular the dual networks, to better
recapitulate cartilage tissue structure on the macroscale.

Figure 3.1. Schematic representation of different strategies utilized to improve the
mechanical properties of hydrogels. (A) Traditional single polymer networks. (B)
Interpenetrating networks (IPNs) comprised of two or more separate crosslinked networks
not covalently bound to each other, but rather partially intertwined. (C) Semi-IPNs
comprised of a crosslinked network with either linear or branched polymers embedded
within the network. (D) Double networks consisted of two networks with significantly
different mechanical properties may crosslinked together. (E) Dual networks consisted of
two materials crosslinked together into the same network with similar crosslinking
mechanisms. (F) Guest-host networks defined as two types of materials interacted rapidly
to form hydrogels via guest-host interactions. Reprinted from Vega, S. L.; Kwon, M. Y.;
Burdick, J. A. Recent advances in hydrogels for cartilage tissue engineering 2017, 33, 5975. Copyright (2016) Burdick, J.A., Open Access. Published by AO Research Institute
Davos.
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We have used the dithiothreitol (DTT)-cross-linked HA hydrogel as a scaffolding
material to study the influence of rod-like nanoparticles on chondrogenesis of MSCs.20
However, the physical properties, particularly mechanical stiffness, of this hydrogel system
were far inferior to native cartilage. It is difficult to further improve the mechanical
stiffness of hydrogels using DTT as the linker because the increased crosslink density with
DTT may compromise the viability of encapsulated cells due to the concentrationdependent toxicity of DTT.21 We therefore explore the usage of other type of cross-linking
agents or combination of DTT with other cross-linking agents as the alternative. With the
aim of increasing the mechanical properties of hydrogels to approach the native cartilage,
this study aimed to examine the effect of cross-linker types on the physical properties of
the thiol–ene “click” HA hydrogels in terms of mechanical stiffness, gelation time,
morphology, solute diffusivity, and degradability. A 4-arm PEG was selected as one of the
cross-linkers due to its biocompatible and highly hydrophilic properties. Importantly, 4arm PEG could provide higher mechanical strength, quicker gelation time and more
sensitive degradation compared to linear PEG, and better support chondrocytes compared
to 8-arm PEG.22,23 Although PEG is inherently cell repellent and nondegradable, these
properties can be readily modified by the chemical modification with native ECM
components24,25 and degradable linkages.26-28 PAMAM dendrimers were another chosen
cross-linkers in this study due to their controllable size, shape, branching length, density,
and surface functionality.29-31 Compared to linear polymers, the multiple-armed
dendrimers may allow more controllable mechanical properties and degradation times by
means of variations in generation and end-group chemistry. Previous studies have shown
that biochemical-modified PAMAM dendrimers and PAMAM-based hydrogels could
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support the adhesion, proliferation and differentiation of MSCs and pheochromocytoma
(PC12) cells without any cytotoxic effects (Figure 3.2).32-34

Figure 3.2. In vitro cell proliferation and differentiation on the biochemical-modified
PAMAM dendrimers. (A) Confocal Microscopic images for viability of differentiated
PC12 cells cultured on substrates coated with native PAMAM carrying DVS (dendrimer
4), RGD modified PAMAM (dendrimer 5), YIGSR modified PAMAM (dendrimer 6), or
IKVAV modified PAMAM (dendrimer 7) in NGF supplemented culture medium for 2 and
4 days. The blue nuclei of cells were stained with DAPI. The green live cells were stained
with Calcein AM. All images share the same scale bar: 50 μm. (B, C) Neurite outgrowth
analysis of PC12 cells cultured on substrates coated with native PAMAM carrying DVS
(dendrimer 4), RGD modified PAMAM (dendrimer 5), YIGSR modified PAMAM
(dendrimer 6), and IKVAV modified PAMAM (dendrimer 7) in NGF supplemented
culture medium for 1 day, 2 and 4 days. (B) Average neurite length of PC12 cells on
different PAMAM dendrimer matrices at different time points. (C) Percentage of cells
displaying neurite outgrowths on different PAMAM dendrimer matrices at different time
points. The values expressed are means (n = 4) ± SD. Samples were compared using twotailed equal variance Student t tests, * P < 0.05, ** P < 0.005, *** P < 0.0005. Reprinted
from Chinese Chemical Letters, 27(9), Maturavongsadit, P.; Bi, X.; Gado, T. A.; Nie, Y.Z.; Wang, Q. Adhesive Peptides Conjugated PAMAM Dendrimer as a Coating Polymeric
Material Enhancing Cell Responses, 1473-1478, Copyright (2016), with permission from
Elsevier (Appendix E).
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We hypothesized that changing structures of the cross-linkers had a considerable
impact on the physical properties of the resulting hydrogels, including gelation time,
mechanical stiffness, morphology, solute diffusivity, and degradability. The ultimate goal
of this study is to improve the in situ-forming HA-based hydrogels in terms of physical
properties for cartilage and bone tissue engineering applications.
3.2 RESULTS AND DISCUSSION
3.2.1 Preparation of Thiol–Ene “Click” HA Hydrogels
Before synthesis of the thiol–ene “click” hydrogels, MeHA with approximate 40%
degree of methacrylate modification was consistently generated by the reaction of HA
monomer and methacrylic anhydride at 1:6 molar ratio as determined by 1H NMR (see
Figure 1.3 in Chapter 1). In addition, PAMAM-G2-16SH and PAMAM-G3-32SH were
synthesized by the reaction of G2- and G3-PAMAM and iminothiolane hydrochloride.
The 1H NMR was used to confirm the existence of the conjugated thiol groups, and the
typical spectra of native PAMAM-G2, native PAMAM-G3, PAMAM-G2-16SH, and
PAMAM-G3-32SH are shown in Figures 3.4 and 3.5. Seven different hydrogel
formulations were successfully formed via thiol–ene “click” reaction at room temperature
and pH ∼ 8 (Figure 3.3 and Table 3.1).
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Figure 3.3. Schematic illustrating the formation of the thiol–ene “click” HA hydrogels.
(A) Synthesis of the thiol–ene “click” HA hydrogel by the reaction between methacrylate
groups on HA and thiol groups on the crosslinkers. (B) The structures of thiol-tailored
crosslinkers used for synthesis of the thiol–ene “click” HA hydrogel.
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Table 3.1. Summary of the thiol–ene “click” HA hydrogel formulations.

Figure 3.4. 1H NMR spectra of the thiol-tailored G2-PAMAM with approximate 100%
degree of modification (16 thiol groups on the structure).
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Figure 3.5. 1H NMR spectra of the thiol-tailored G3-PAMAM with approximate 100%
degree of modification (32 thiol groups on the structure).
In the preliminary step, the formulation of the hydrogels was optimized by
considering three variables: cross-linking molar ratio (thiol:ene), cross-linker
concentration, and total polymer concentration. The different cross-linking molar ratios, in
the range of 1SH:4Ene to 4SH:1Ene, were first studied in each hydrogel by fixing HA
concentration at 5% w/v (based on our previous work in Chapter 1). We found that the
comparison in the effect of cross-linkers by controlling the cross-linking molar ratio was
not practical. Different hydrogel formulations would result in a large difference in total
polymer concentration that would eventually have a high impact on cell survival.
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Specifically, at the ratio 4SH:1Ene, G2 and G3 concentrations were approximately 1.5%
w/v of the hydrogel solution while PEG concentration was 25%, resulting in no survival
cells observed (data not shown). In addition, increasing concentration of DTT was limited
by its concentration-dependent toxicity. We found that the 2SH:1Ene was the maximum
ratio of DTT that could support cell survival (data not shown). Moreover, the studies by
Erickson et al. and Bian et al. have used 3% w/v of HA contained in the hydrogels for
promotion of chondrogenesis and matrix formation. Therefore, we minimized the HA
concentration to 3% w/v and compared the effect of cross-linkers by controlling
concentrations.6,35 The cross-linker concentrations in the range of 1–5% w/v were studied
in each hydrogel (except DTT). Increasing the concentration of cross-linkers leads to the
increase in total polymer concentration, which afforded a higher modulus. However, there
were less than 70% of survival cells in the hydrogels containing more than 2% w/v of crosslinkers. Taken all into account, the formulations composed of 3% w/v of HA and 2% w/v
of cross-linkers were selected as the master recipes in this research in order to study the
improvement of the mechanical properties of the hydrogels influenced by the cross-linkers.
3.2.2 Effect of Cross-Linkers on Physical Properties of Thiol–Ene “Click” HA Hydrogels
3.2.2.1 Microstructure of the Hydrogels
The morphology of the seven different hydrogels was determined by SEM
micrographs (Figure 3.6). The differences in pore size, porosity, and interconnectivity were
observed among the different hydrogels. Namely, pore size of DTT hydrogel was in a range
of 100–150 μm. While G2 and G3 hydrogels showed large pore sizes, a range of 100–200
μm, G2DTT and G3DTT hydrogels provided smaller pore sizes, a range of 70–110 and
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50–100 μm, respectively. PEG hydrogels displayed a range of 100–200 μm in pore size,
whereas PEGDTT exhibited smaller sizes, 10–100 μm. Moreover, DTT, G2, G2DTT, G3,
and G3DTT hydrogels presented a high density of macropores which were wellinterconnected with thin layers of compacted outer edge. PEG hydrogels displayed lower
degree of porosity and interconnectivity with thicker compacted outer edges. The porous
structure of PEGDTT hydrogels was the most compact with the lowest degree of porosity
and interconnectivity. The exterior surfaces of all hydrogels were rough, folded, and dense.
Especially, PEG and PEGDTT hydrogels were denser compared to other hydrogels.

Figure 3.6. Exterior and cross-section SEM micrographs of the thiol–ene “click” HA
hydrogels after freeze-drying. Scale bars for all images: 100 μm.
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3.2.2.2 Mechanical Properties and Gelation Time of the Hydrogels
The mechanical properties of the hydrogels were determined by observing the
complex modulus. It revealed that the average complex modulus of PEG and PEGDTT
hydrogels were the highest (∼1800 Pa) and was followed by G2DTT (∼1240 Pa), G2 ∼
G3DTT (∼600 Pa), DTT (∼400 Pa), and G3 hydrogels (∼270 Pa), respectively (Figure
3.7A). As shown in Figure 3.7B, the gelation times of DTT, PEG, and PEGDTT hydrogels
were similar and fastest, approximately 1 h, followed by G2DTT (∼3 h), G2 ∼ G3DTT
(∼5 h), and G3 (∼18 h), respectively. The incorporation of DTT cross-linkers could further
promote elasticity of the G2 and G3 hydrogels and shorten gelation time of the hydrogels
(G2DTT and G3DTT compared to G2 and G3, respectively). We observed that the gelation
time of the hydrogels, except for DTT hydrogel, was correlated nicely to the stiffness of
the hydrogels such that the hydrogels with higher complex modulus showed faster gelation
time.

Figure 3.7. Mechanical properties and gelation time of the thiol–ene “click” HA hydrogels.
(A) Average complex modulus of the hydrogels after gelation for 2 days (n = 4). (B)
Average gelation time of the hydrogels (n = 6).
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In hydrogel formation steps, the result obviously showed that the structure of crosslinker affected the gelation time of the thiol–ene “click” HA hydrogels. The overall rate
and yield of Michael reactions are influenced by solvent polarity and pH, base catalyst
strength, and steric bulk of the thiol group.36 As shown in Figure 3.7, even providing higher
thiol cross-linking sites, using large rigid and sterically bulky complex structure as
PAMAM dendrimer led to longer gelation time compared to using small linear structure as
DTT or branch polymer as 4-arm PEG. Furthermore, the hydrogel formed by larger (G3)
PAMAM dendrimer showed significantly longer gelation time compared to using smaller
(G2) PAMAM dendrimer. It showed that the flexibility and steric hindrance of the crosslinkers influenced the ability of MeHA to react with the tailored thiols. As expected, the
combination of DTT could significantly fasten the gelation time of both PAMAM
hydrogels. We believe that DTT helped to react to unoccupied methacrylate groups on HA
of PAMAM hydrogels. Conversely, it could not help in PEG hydrogel because 4-arm PEG
could effectively react to methacrylate groups on HA to form hydrogel. The mechanical
property of the hydrogels is related to the properties of cross-linkers and the cross-linking
density, dictated by the structure of cross-linkers. Specifically, PEG and PEGDTT
hydrogels showed the similar highest stiffness because of a highly molecular weight
polymer and effectively cross-linking of PEG. G3 hydrogels showed the lowest stiffness
since the rigidity and steric hindrance of the bulky structures caused the low cross-linking
density. The combination of DTT with G2- or G3-PAMAM dendrimers could significantly
improve the stiffness of the G2 or G3 hydrogels by increasing cross-linking density. The
microstructure of the hydrogels measured by SEM supports the result of mechanical
properties. The hydrogels with a thicker layer of interior compacted outer edge and a denser
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exterior surface (PEG and PEGDTT) exhibited higher mechanical stiffness. The G2DTT
and G3DTT hydrogels with a smaller average pore size showed higher mechanical stiffness
compared to G2 and G3 hydrogels because of increasing in cross-linking density. Although
PEG and PEGDTT hydrogels provided the similar gelation time and mechanic stiffness,
PEGDTT hydrogels exhibited a smaller average pore size and less porosity compare to
PEG hydrogels. It could be explained by a formation of disulfide bond between the thiol
groups of 4-arm PEG and DTT, leading to less available thiol groups to form thiol–ene
linkages. Thus, the smaller average pore size and less porosity were observed in PEGDTT
hydrogels.
3.2.2.3 Swelling Properties and Permeability of the Hydrogels
The swollen hydrogels reached the swelling equilibrium after being immersed in
PBS for 2 days. We observed that swelling ratios of all hydrogels maintained the same after
14 days (data not shown). The water content and swelling ratios of the hydrogels are shown
in Figure 3.8. All of the hydrogels had water content more than 90%. The swelling ratios
of G3 hydrogel showed the highest (Qm ∼ 70, Qv ∼ 86) and were followed by G2 (Qm ∼
59, Qv ∼ 72), DTT ∼ G3DTT ∼ G2DTT (Qm ∼ 40, Qv ∼ 50), and PEG ∼ PEGDTT
hydrogels (Qm ∼ 16, Qv ∼ 20), respectively. The statistically lower water content and
swelling ratios were observed for G3DTT and G2DTT compared to G3 and G2 hydrogels,
respectively.
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Figure 3.8. Swelling properties of the thiol–ene “click” HA hydrogels. (A) Water content
of the hydrogels after being immersed in PBS for 2 days. (B) Mass-based swelling ratios
of the hydrogels. (C) Volumetric-based swelling ratio of the hydrogels (n = 6).
The release of BSA proteins from the hydrogels was observed during 24 h. As
shown in Figure 3.9A, the release of BSA from PEG and PEGDTT hydrogels was
completed in 15 min, while the release of BSA from other hydrogels was not completed in
24 h. The release of BSA was rapid and became slower after 15 min in DTT and G2DTT
hydrogels, 30 min in G3DTT hydrogels, and 60 min in G2 and G3 hydrogels. The total
amount of BSA accumulated in the hydrogels was calculated by totaling BSA release
during 24 h and any BSA entrapped within the hydrogels after 24 h (Figure 3.9B). In
general, the total BSA accumulation in the hydrogels showed a similar trend to the swelling
properties of the hydrogels. Namely, the total BSA accumulation in the G2 and G3
hydrogels showed the similar highest (∼100 μg) and were followed by G3DTT (∼72 μg),
DTT ∼ G2DTT (∼45 μg), and PEGDTT ∼ PEG hydrogels (∼13 μg).
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Figure 3.9. Permeability of the thiol–ene “click” HA hydrogels. (A) BSA release profile
of the hydrogels showing the cumulative amount of BSA released from the hydrogels to
supernatant for 24 h. The inset shows the BSA release profile of the hydrogels in first 60
min. (B) Total amount of BSA accumulated in the hydrogel scaffolds (n = 6).
The swelling properties, BSA release profile, and BSA accumulation were
associated with the mechanical property and microstructure of the hydrogels. Overall, the
hydrogels with a lower mechanic stiffness, larger pore size, and thinner layer of outer edge
provided higher swelling properties, BSA release and BSA accumulation. The chemical
properties of the cross-linkers should be also considered for BSA accumulation. As shown
in Figure 3.8B, the BSA accumulation in both PEG and PEGDTT hydrogels was greatly
lower than others. It could be the result of inherently protein-repellent properties of PEG,
besides the hydrogel architectures. PEG rarely adsorb proteins since the surfaces of PEG
can interact to a number of water molecules via hydrogen bonds and form repulsive forces
to proteins.37
3.2.2.4 Degradation Time of the Hydrogels
The amount of uronic acid released in a solution of 100 U hyaluronidase/mL of
PBS is shown in Figure 3.10A. For DTT as well as G2 and G3 hydrogels, more than 65%
of uronic acid was found within 1 day of degradation, and the complete degradation was
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observed within 2 or 3 days. For G3DTT hydrogels, ∼90% of the uronic acid was detected
within 3 days, and then the degradation extended to 6 days. PEG and PEGDTT hydrogels
showed a similar degradation profile; more than 50% of the uronic acid was observed
within 3 days, and the complete degradation extended to 10 days. The slow release of
uronic acid was observed in G2DTT hydrogel; ∼40% of uronic acid was found in the first
3 days, then the degradation rate was slower until 5 days, and the complete degradation
was observed ∼13 days. The complete degradation time of the hydrogels in the
hyaluronidase solutions is shown in Figure 3.10B.

Figure 3.10. Degradation of the thiol–ene “click” HA hydrogels. (A) Degradation profile
of the hydrogels plotted as the percentage of total uronic acid released with degradation
time. (B) Degradation time of the hydrogels (n = 3).

The degradation of the hydrogels by hyaluronidase was from the cleavage of HA
at the endo-β-N-acetyl-d-glucosaminidic linkages, resulting in oligomers with Nacetylglucosamine and glucuronic acid. Overall, the size of the hydrogels was decreased
during exposure to the hyaluronidase, which was similarly observed in other cross-linked
HA hydrogels.38 Importantly, we observed a good correlation between the degradation time
and microstructure and swelling properties of the hydrogels. Also, it should be noted that
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the results are only relative degradation times. The actual in vitro degradation times depend
on the concentration of hyaluronidase from cells.
3.3 CONCLUSIONS
The structure of thiol-tailored cross-linkers significantly influences the physical
properties of the thiol–ene “click” HA hydrogels by change the morphology, mechanical
stiffness, permeability, and degradation rate of the hydrogels. The 4-arm-PEG cross-linker
generated the highest stiffed hydrogel, largest pore size, lowest permeability, and longest
degradation time compared to the hydrogels created by DTT and PAMAM cross-linkers.
The PAMAM cross-linkers, both G2 and G3, did not improve the mechanical properties of
the hydrogels, but promoted a wider range of pore sizes, higher permeability, and longer
degradation rate compared to the DTT-HA hydrogels. The combination of PAMAM and
DTT cross-linkers could create higher mechanical properties, porosity, smaller pore sizes
compared to their individual-crosslinked hydrogels. However, the combination of 4-arm
PEG and DTT did not showed significantly improved mechanical properties of the
hydrogels, instead, it generated a less porous hydrogels compared to their individualcrosslinked hydrogels.
3.4 MATERIALS AND METHODS
3.4.1 Modification of HA
Methacrylated

HA

(MeHA)

was

synthesized

following

the

literature

protocols.20,39,40 Briefly, HA of molecular weight 47 kDa (Dali) was dissolved at 1 wt% in
potassium phosphate buffer, pH 8, and methacrylic anhydride (Alfa Aesar) of 6-fold molar
excess (relative to the HA disaccharide repeat unit) was added dropwise to the solution at
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0 C. The pH of the two-phase reaction mixture was adjusted to 8.0 with 5 M NaOH aq.,
and the reaction continued for 24 h at 4 °C with frequent re-adjustment of the solution pH.
The product was dialyzed against Milli-Q water for at least 48 h, followed by centrifugation
to remove the precipitate, which was then flash frozen in liquid nitrogen, and lyophilized,
resulting in powder which was analyzed degree of modification by 1H NMR.
3.4.2 Synthesis of Thiol-tailored G2 and G3 PAMAM Dendrimers
PAMAM dendrimer of generation 2 and generation 3 (G2- and G3-PAMAM) with
amine terminal groups was ordered from Dendritech Inc. (Midland, MI, USA). 2Iminothiolane hydrochloride was ordered from Chem-Impex International, Inc. (Wood
Dale, IL). Compounds were used in the synthesis without further purification.
To synthesize thiol-tailored G2-PAMAM (PAMAM-G2-16SH), G2-PAMAM (281
mg, 0.0863 mmol) was dissolved in deionized water (15 mL) before 2-iminothiolane
hydrochloride (190 mg, 1.38 mmol) was added to the dendrimer solution. Nitrogen gas was
bubbled into the solution to replace oxygen in solution as well as in the reaction flask. The
resulting mixture was stirred at room temperature for 24 h. The product G2-16SH (383 mg)
was obtained in 91% yield after membrane filtration through a 1,000-molecular weight cutoff (MWCO) membrane followed by lyophilization. The degree of thiolation was
confirmed by 1H NMR and MALDI-TOF analyses.
To synthesize thiol-tailored G3-PAMAM (PAMAM-G3-32SH), G3-PAMAM (388
mg, 0.0561 mmol) was dissolved in deionized water (20 mL). 2-Iminothiolane
hydrochloride (247 mg, 1.80 mmol) was added to the dendrimer solution. Nitrogen gas was
bubbled into the solution to replace oxygen in solution as well as in the reaction flask. The
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resulting mixture was stirred at room temperature for 24 h. The product G3-32SH (507 mg)
was obtained in 89% yield after membrane filtration through a 1,000-MWCO membrane
followed by lyophilization. The degree of thiolation was confirmed by 1H NMR and
MALDI-TOF.
3.4.3 Hydrogel Formation
Seven different HA hydrogels were formed via thiol–ene “click” reaction (see
Table 3.1 and Figure 3.3). To form the thiol–ene “click” HA hydrogels, MeHA polymers
with approximate 40% degree of modification were dissolved in a phosphate buffered
saline solution (PBS) at 3 wt% concentration, and the PAMAM-G2-16SH, PAMAM-G332SH or 4-arm thiol-tailored PEG (Jenkem Technology, PEG-4SH) in PBS was added to
make a final concentration of 2 wt% (the calculated molar ratio of thiol:ene in each
formulation was shown in Table 3.1). The pH of the mixture was adjusted to 8.0 with 2 M
NaOH aq. For enhancing matrix stiffness purposes, DTT crosslinkers was then additionally
added at a molar ratio of thiol:ene = 2:1. For comparison purposes, the thiol–ene “click”
HA hydrogels were also synthesized by the same procedure with only DTT as a crosslinker.
3.4.4 Microstructure Analysis
Microstructure of the hydrogels was characterized using Scanning Electron
Microscope (SEM). The hydrogel samples were lyophilized, then cross-sectioned and
mounted on metal stubs with carbon tape. The samples were sputtered coated with
gold/palladium for 30 sec on a Denton Desk II sputter coater with global rotation and tilt.
The surfaces of the gold/palladium-coated hydrogels samples were observed at 5-8 random
locations per sample (n = 3) on a Zeiss Ultraplus Thermal Field Emission SEM at 10 kV.
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3.4.5 Gelation Test
The hydrogels were prepared previously described by using PBS as the medium.
The gelation time was measured by the vial tilting method.41 When the sample showed no
flow within 20 s, it was considered as being completely formed hydrogel.
3.4.6 Mechanical Properties
Oscillatory shear test was performed using a DHR-3 rheometer (TA instrument)
with 12 mm diameter parallel-plate geometry and temperature controlled Peltier plate. The
hydrogels were prepared previously described by using PBS as the medium. After gelation
for 2 days, the samples were cut into uniform cylinders and placed on a metal plate, where
the tests were performed. Amplitude sweeps at constant frequency (1 rad/s) were
performed to determine the linear viscoelastic range of deformation for each sample, after
which frequency sweeps (0.1-10 rad/s) were performed at a strain amplitude within the
linear range (1%). In amplitude and frequency sweeps measurement, the geometry gaps
were conditioned by axial force at 0.2 N for every run.
3.4.7 Swelling Properties
The hydrogels were prepared from 50 μL of polymer solutions. Hydrogels were
allowed to swell for 2 days in PBS and were then blotted to remove excess water and
weighed to obtain the swollen hydrogel mass, Ms. These hydrogels were then dried by
lyophilizing to determine the final dry mass, Md. After that, water content and swelling
ratios were calculated from the swollen and dry hydrogel masses. The percent water
content was determined by:
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(Ms −Md /Ms) ×100 = water content
The mass based swelling ratio, QM, was calculated by dividing the hydrogel mass
after swelling, Ms, by the mass after the hydrogel has dried, Md. The volumetric based
swelling ratio, Qv, was then calculated from QM according to equation:
Qv =1+ρp /ρs (QM −1)
where ρp is the density of the dry polymer (1.229, 1.222, and 1.094 g/cm3 for MeHA,
PAMAM, and PEG-4SH, respectively) and ρs is the density of the solvent (1 g/cm3 for
water). Values for ρp of the G2, G2DTT, G3, G3DTT, PEG and PEGDTT hydrogels were
calculated by estimating the molar volume for the PAMAM-G2-16SH/MeHA, PAMAMG3-32SH/MeHA or PEG-4SH/MeHA polymer segment and divided by the molecular
weight of the segment.
3.4.8 Protein Release Profile and Protein Accumulation
To study the protein release profile and protein accumulation within the hydrogels,
bovine serum albumin (BSA) was chosen as the model solute for diffusion. To mimic
exogenously supplemented growth factor accumulation in 3D tissue engineering scaffolds,
the premade hydrogels (2 mm thickness, 4 mm diameter) were immersed in BSA solution
(1 mg/ml) at room temperature for 30 h to achieve uniform protein loading. For protein
diffusivity on the order of 10−7 cm2/s, the diffusion time is 15 h for a diffusion length of
1.5 mm (t ∼ L2/4D). Therefore, a 30-h loading time should be sufficient to achieve
equilibrium protein concentrations within the hydrogels. The loading time observed in
similar studies of various model proteins through even denser polymer networks further
support the rationale for a 30 h loading time.42
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To study the protein release profile, the BSA-loaded hydrogels were immersed in
PBS. All supernatant was collected and replaced by fresh PBS at different time points
(t = 5, 10, 15, 30, 45, 60, 90, 120 min and 24 h). Any proteins that remained entrapped in
the hydrogels after 24 h were released by mechanically breaking down the hydrogels in
fresh PBS using a homogenizer. To quantify the protein in the supernatant, a Coomassie
(Bradford) protein assay (Thermo scientific) was performed following the manufacturer’s
protocol. The standard calibration curve of BSA was also established in order to determine
the amount of BSA (Figure 3.11).
Protein accumulation was calculated from the protein released into supernatant at
different time points and the protein that remained trapped in the gel after the 24 h release.

Figure 3.11. Fluorescence spectroscopy calibration with linear fitting curve and equation
for quantification of BSA proteins at concentration of 0-25 µg/mL (A), and 50-1000 µg/mL
(B).
3.4.9 Degradation Profile
Hydrogels (40 µL, 2 mm thickness, 4 mm diameter) were loaded into a 48-well
plate. The samples were digested in 400 µL of 100 U hyaluronidase (Sigma) in PBS
(replaced every 24 h throughout the study and stored frozen until analysis) at 37°C. The
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amount of uronic acid (a degradation component of HA) released during degradation was
measured using a carbazole assay in a 96-well plate.43 Briefly, 50 μL of the degradation
solution was added in a 96-well plate. 200 μL of a solution of 25 mM sodium tetraborate
in sulfuric acid was added. The plate was heated for 10 min at 100 °C in an oven. After
cooling at room temperature for 15 min, 50 μL of 0.125% carbazole in absolute ethanol
were carefully added. After heating at 100 °C for 10 min in an oven and cooling at room
temperature for 15 min, the plate was read in a SpectraMax M2 Multi-Mode microplate
reader (Molecular Devices) at a wavelength of 550 nm. Any possible lid on the plate was
avoided as a decrease in the reaction intensity.43

The amount of uronic acid was determined using a serial dilution of 1 mg/mL of
the 47 kDa HA solution as a standard (Figure 3.12). The time for complete degradation of
the hydrogels was reported as no amount of the uronic acid and scaffold remainder were
observed. The percent degradation at each time point was calculated by dividing the
amount of uronic acid released at a given time point by the final amount of uronic acid
collected when the hydrogel was completely degraded.

Figure 3.12. UV-Vis spectroscopy calibration with linear fitting curve and equation for
quantification of HA at concentration of 0-1 mg/mL.
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CHAPTER 4
THE IN VITRO MESENCHYMAL STEM CELL CHONDROGENESIS
AND OSTEOGENESIS IN DIFFERENT THIOL–ENE “CLICK” HA
HYDROGELS1
4.1 INTRODUCTION
Osteochondral defects are the results of traumatic injuries or natural degradation
of cartilaginous tissue by aging and involve serious damages to articular cartilage and
underlying calcified subchondral bone.1 The techniques for osteochondral repairs are
limited because of low self-healing capacity of damaged cartilage,2-4 donor-site morbidity,
potential infection, and low integration with surrounding tissues.5-8 Hence, the research in
osteochondral tissue engineering has been extensively investigated and developed.9,10 Yet,
many challenges remain to be addressed in fabricating tissue-engineered scaffolds to
optimally achieve osteochondral regeneration. One of the major challenges of developing
scaffolds for cartilage and bone tissue engineering is the design of scaffolds that have
perfect biocompatibility, biodegradability, and favorable physical and mechanical
properties for 3D cell differentiation.11 We have tried to address this challenge by
developing novel in situ thiol–ene “click” HA hydrogels which were presented in previous
chapter. Herein, we aimed to use the developed thiol–ene “click” hydrogels for promotion

1

Portions of this chapter were adapted with permission from Maturavongsadit, P.; Bi, X.; Metavarayuth, K.;
Amie Luckanagul, J.; Wang, Q. ACS Applied Materials and Interfaces 2017, 9 (4), 3318–3329. Copyright
(2017) American Chemical Society (Appendix D).
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of cartilage and bone differentiation of bone marrow mesenchymal stem cells (BMSCs),
which is ultimately for osteochondral regeneration. The effect of the physical and
mechanical properties of the developed thiol–ene “click” hydrogels on BMSCs
chondrogenesis and osteogenesis were particularly studied (Figure 4.1). We hypothesized
that these properties had a highly impact on the performance of chondrogenic and
osteogenic differentiation of BMSCs.

Figure 4.1. Schematic illustration of the research design for the study of the effect of crosslinker types on the chondrogenic and osteogenic differentiation by encapsulated BMSCs
in the thiol–ene “click” HA hydrogels.
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4.2 RESULTS AND DISCUSSION
4.2.1 Effect of Thiol–Ene “Click” HA Hydrogels on Viability of BMSCs
Before evaluation of the chondrogenic differentiation of BMSCs, the
biocompatibility of the hydrogels was confirmed by CTB metabolic assay. BMSCs were
encapsulated in the preformed hydrogel solutions at a concentration of 1 × 106 cells/mL.
However, we observed that the gelation times of the encapsulated BMSC-G2 and -G3
hydrogels were longer than 12 h, which were unsuitable for in vitro study. The metabolic
activities of the encapsulated BMSCs in other five hydrogels (DTT, G2DTT, G3DTT,
PEG, and PEGDTT) indicated that more than 70% of the viable cells was observed in all
groups after 7 days of culture (Figure 4.2C). However, the decrease in viability was seen
in all hydrogels, especially in G3DTT hydrogels. The highest sustained viability was
observed in DTT hydrogels. It is likely because the high cross-linking density and matrix
stiffness can affect the transportation of nutrients and wastes between the culture media
and encapsulated cells, which lead to compromised cell viability.12 Nevertheless, the
viability in the G3DTT hydrogels decrease significantly compared to the viability in other
groups. It is conceivably due to incomplete modification of thiol group on G3-PAMAM
dendrimers. Studies have showed that the toxicity of PAMAM dendrimers is dependent on
their structures,13,14 dose/concentration,15-17 exposure duration, and generation.15,16 The
modification of the terminal groups of PAMAM dendrimer with negatively charged or
neutral groups can reduce the toxicity.16-18
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4.2.2 The Effect of Thiol–Ene “Click” HA Hydrogels on the In Vitro Chondrogenesis of
MSCs
The stain for GAG of the encapsulated BMSC hydrogels under chondrogenic
condition is shown in Figure 4.2A, and the quantitative analysis of the corresponded GAG
signal intensities in Figure 4.2B. While light background staining was observed for the
control hydrogels due to the HA composition (see Figure 4.3A), a more intense staining
was observed in all hydrogels after 14 and 28 days of culture. Overall, the staining for GAG
in all groups was consistently distributed. PEG hydrogels showed the significantly highest
accumulation after 28 days. No significant difference of GAG values was observed among
DTT, G2DTT, G3DTT, and PEGDTT hydrogels after 28 days.

Figure 4.2. BMSC viability after culturing in complete growth media, and GAG
accumulation of differentiated BMSCs in the hydrogels after culturing in chondrogenic
media. (A) Histochemical staining for GAG (red) of differentiated BMSCs in the hydrogels
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after 14 and 28 days of chondrogenic culture. The scale bar for all images: 100 μm. (B)
The quantified signal intensities of GAG, shown in (A), normalized to the intensity of
cytoplasm signal (green). (C) Cell metabolic activity of viable BMSCs in the hydrogels
detected by Cell Titer-Blue assay. The intensity was normalized to the intensity values of
day 0 for each hydrogel. Statistics: ANOVA with Tukey’s multiple comparisons tests, n =
4, *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001.

Figure 4.3. Negative controls of histochemical staining for GAG and immunohistostaining
for type II and I collagen. (A) Histochemical staining for GAG (red) of non-differentiated
BMSCs in the hydrogels after 3 days culturing in primary media (DTT-G) and after cell
encapsulation (day 0) under chondrogenic condition. (B) Confocal images of nondifferentiated BMSCs in the hydrogels under chondrogenic condition stained for nucleus
(blue) type II collagen (red) and type I collagen (green) after cell encapsulation (day 0).
All images share the same scale bar: 100 µm.
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The immunohistochemical staining for type II collagen (chondrogenic marker) and
type I collagen (hypertrophic marker) were further performed to evaluate the
chondrogenesis of differentiated BMSC in the hydrogels. No color background was
observed for the control hydrogels (see Figure 4.3B). Along culture period time, the
staining of type II collagen in DTT, PEG, and PEGDTT groups was increasingly intense
and mostly localized to the cellular region (Figure 4.4A, C). On the other hand, the staining
of type II collagen in G2DTT and G3DTT groups was distributed lightly throughout the
networks. PEG groups showed the highest of type II collagen accumulation, whereas
G2DTT and G3DTT had the similar lowest of type II collagen accumulation. Unlike type
II collagen results, on day 28, G2DTT and G3DTT groups displayed significantly more
intense of type I collagen in the networks compared to DTT, PEG, and PEGDTT groups.
It is widely accepted that the quality of chondrogenesis of BMSCs is associated
with subsequent hypertrophic differentiation, producing type I and X collagen, Runtrelated transcription factor 2 (Runx2), alkaline phosphatase (ALP), and calcifications. The
differentiated cells should produce substantial amounts of GAG and collagen type II
instead of type I, in order to successfully form cartilage tissues.19 In our results, the cells in
PEG hydrogels showed the significantly highest GAG and type II collagen accumulation,
while exhibiting the significantly lowest type I collagen accumulation compare to other
hydrogels. In contrast, the cells in G2DTT and G3DTT hydrogels displayed the
significantly lowest GAG and type II collagen accumulation, while exhibiting the
significantly highest type I collagen accumulation. One plausible explanation for this
observation relates to the mechanical stiffness, permeability, pore size, porosity, and
chemistry of cross-linkers. In 2D systems, it has been shown that stiff substrates supported
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chondrogenesis and suppressed chondrocyte hypertrophy by upregulation of a
mechanotransduction mechanism through RhoA/ROCK signaling.20 However, in 3D
systems, the medium stiff matrix (∼1–3 kPa) could support in vitro and in vivo
chondrogenesis better than lower or higher stiffness.21-23 Although the matrix stiffness of
the ECM was shown to have crucial impacts in directing stem cell differentiation, it is not
the only contributing factor to explain the phenomenon. Previous studies suggested that
reducing the permeability of the scaffold was beneficial for chondrogenesis and would
further reduce the amount of fibrous tissue formation, such as type I collagen, within the
defect.24,25 However, if the permeability of the scaffold is too low, it also leads to increased
cell death. Whereas PEG and PEGDTT hydrogels provided the similar high stiffness and
low permeability, the chondrogenesis in PEG hydrogels were significantly higher. It could
be a result of the difference in pore size (100–200 μm for PEG hydrogels and 10–100 μm
for PEGDTT hydrogels). Studies have suggested that larger pore sizes facilitated more
newly secreted matrix. Chondrocytes in the scaffolds with pore size between 250 and 500
μm showed better ECM production and cell phenotype maintenance compared to the
smaller ones (100 μm).26-28 The cells in the smaller pores and high porosity often appeared
as a dedifferentiated form, which also support our result showing the high production of
type I collagen in G2DTT and G3DTT hydrogels.
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Figure 4.4. Type II and I collagen accumulation of differentiated BMSCs in the hydrogels
after culturing in chondrogenic media. (A, B) Immunohistochemical staining for nucleus
(blue), type II collagen (red), and type I collagen (green) of differentiated BMSCs in the
hydrogels after 14 and 28 days of chondrogenic culture. The scale bars for all images: 100
μm. (C, D) The quantified signal intensities of type II and type I collagen shown in (A) and
(B), respectively, normalized to the intensity of nucleus signal. Statistics: ANOVA with
Tukey’s multiple comparisons tests, n = 4, *p < 0.05, **p < 0.01, ***p < 0.005, ****p <
0.001.
101

Furthermore, the difference in chemistry of cross-linkers inside the hydrogels could
also play a role. Evidence for this lies in the distribution of ECM components, such as type
I and type II collagen, in the different hydrogel types. In DTT and PEG hydrogels, the cells
produced ECM matrix and formed pericellular compact islands (Figure 4.4). In contrast,
within PAMAM hydrogels, the secreted ECM products spread out in ECM network, likely
due to the interaction between the PAMAM dendrimer linkers and the collagen I
matrices.29 While PEG has an intrinsic bioinert property, resulting in localization of Col I
within the cells.30
4.2.3 The Effect of Thiol–Ene “Click” HA Hydrogels on the In Vitro Osteogenesis of MSCs
We further studied the in situ hybrid-HA hydrogels for facilitating the in vitro bone
differentiation of MSCs in which the ultimate goal is to use as a hydrogel for osteochondral
tissue regeneration. Early stage of osteogenesis of BMSCs encapsulated in the hydrogels
was evaluated by in situ ALP activity assay on day 3 and 7 under osteogenic condition. As
shown in Figure 4.5B, on day 3, ALP activity of BMSCs in PEG groups was highest
compared to other groups. However, on day 7, the increase of ALP activity in G2DTT and
PEG hydrogels were similar and significantly highest compared to other groups. Moreover,
late stage of osteogenesis of BMSCs was evaluated by calcium staining on day 14 and 28
under osteogenic condition (Figure 4.5A). The background staining was observed for the
control G2DTT and G3DTT hydrogels, yet the calcium stain was observed in the networks
on day 28. Specifically, it primarily deposited on the outer of the G2DTT and G3DTT
constructs, and somewhat in the middle of G3DTT constructs. For DTT, PEG and
PEGDTT hydrogels, the control hydrogels displayed no background staining. The stain of
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calcium in PEG constructs distributed in both inner and outer of the constructs and was
highest compared to other constructs along the culture period time. Conversely, there was
a small stain of calcium exhibited in PEGDTT networks.
Using these observed ALP activity and calcium mineralization, we estimate that
the promotion of encapsulated-MSC osteogenesis is principally offered by matrix stiffness
and pore architecture of the scaffolds, which were optimum approximately 1.6 kPa, 100200 µm and moderate porosity, respectively. Numerous studies proved that the matrix
stiffness of the scaffold is a key parameter governing the capacity of osteogenesis.31 The
study by Chen, et al. has elicited a according relationship of matrix stiffness and the
accumulation of bone matrix proteins in 3D hydrogels.32 Although PEG hydrogels in our
study highly supported MSC osteogenesis, Huebsch, et al. found that the MSC
osteogenesis occurred principally at 11–30 kPa in 3D hydrogels.33 Although the underlying
mechanism remains unclear, environmental stiffness may be perceived by the cell via the
adhesion molecules to regulate the intracellular stress and subsequently the RhoA/ROCK
signaling pathway for the ultimate control of cellular functions.34,35 Additionally, based on
our findings, it could be concluded that not only matrix stiffness but pore size and porosity
of the hydrogels also greatly impacted osteogenesis of MSCs, in similar way to MSC
chondrogenesis.26-28 Based on the study of Hulbert et al., the minimum pore size for
mineralized bone regeneration is considered to be approximately 100 μm. Namely, the
scaffold with large pores between 100–200 μm showed substantial bone ingrowth. In
contrast, smaller pores between 75–100 μm demonstrated solely the ingrowth of osteoid
tissue (unmineralized bone matrix), and smallest pores between 10–75 μm were penetrated
only by fibrous tissue.36 It was believed that larger pores could allow vascularization and
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high oxygenation which flavor to enhance osteogenesis.37 Nevertheless, the appropriate
pore size distribution for promotion of MSC osteogenesis remains open. Some studies have
reported that MSC osteogenesis was not affected by pore size, rather was assisted by
porosity.38,39 Higher porosity better support osteogenesis due to facilitating ion exchange
and nutrients,40,41 which agrees to our results compared between PEG and PEGDTT
hydrogels.
Taken together, the physical properties of HA hydrogels varied by the structure of
cross-linker, shown in Table 4.1, significantly impact on the potential of BMSC
differentiation. The needs of appropriate physical properties, such as mechanical
properties, morphology (pore size and porosity), permeability, and degradation rate, set
challenges for fabricating biomaterial scaffolds for the specific site of application.
Table 4.1. Summary of the impact physical properties of the thiol–ene “click” HA
hydrogels on BMSC differentiation.
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Figure 4.5. Osteogenesis performance of differentiated BMSCs in the hydrogels after
culturing in osteogenic media. (A) Histochemical staining for calcium accumulation (red)
of differentiated BMSCs in the hydrogels under osteogenic conditions after 14 and 28 days.
(n = 4, *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001). (B) ALP activities of
differentiated MSCs in the hydrogels under osteogenic conditions after 3, and 7 days. ALP
activities were performed by p-nitrophenyl phosphate assay
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4.3 CONCLUSIONS
The results of in vitro tests indicated all thiol–ene “click” HA hydrogels showed a
good cell response in terms of viability but provided different chondrogenic and osteogenic
performances. The evaluation of both chondrogenic and osteogenic differentiation markers
through the measurement of glycosaminoglycan (GAG) and collagen accumulation,
alkaline phosphatase (ALP) activity and calcium accumulation, the MSC differentiation
was mostly supported in the PEG-cross-linked HA hydrogel, which is likely due to the
optimum in the mechanical stiffness, permeability, pore size, and porosity of the hydrogels,
compared to the other types of thiol–ene “click” HA hydrogels. The further in vivo study
of the biocompatibility and cartilage regeneration using the PEG cross-linked HA scaffolds
is the straightforward step for development of the injectable hydrogel for cartilage tissue
regeneration.
4.4 MATERIALS AND METHODS
4.4.1 In Situ Cell Encapsulation, Chondrogenic and Osteogenic Culture
The hydrogels were prepared previously described in chapter 3 except that the
preparation occurred under sterile condition and pre-warmed complete DMEM media was
used to dissolve the polymer. BMSCs passage 3 or 4 were harvested from the 75 cm2 tissue
culture plate (Corning) after reaching 80% confluency. The cells were then trypsinized,
counted, centrifuged, and gently mixed with the mixture of pre-warmed hydrogel in
DMEM media at concentration of 106 cells/mL in the final suspension right after addition
of the crosslinkers. The cells-hydrogel mixture (50 µL containing 5×104 cells) was then
pipetted into each sterile 1 mL syringe mold (Norm-Ject®). After gelling, the hydrogels in
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syringe molds were transferred to ultra-low attachment 24 well tissue culture plate and
incubated at 37 °C in a CO2 incubator with 5% CO2/95% air. Chondrogenic or osteogenic
media (1 mL) was added into each well to induce chondrogenesis or osteogenesis. The
media was exchanged every 2 days for the entire experimental period.
Chondrogenic media is comprised of DMEM supplemented with 1% FBS, 1×
Penicillin-Streptomycin-Amphotericin B (from MP Biomedicals, 100 U/mL penicillin and
1000 U/mL streptomycin solution, 0.25 μg/mL amphotericin B), 100 nM dexamethasone
(Enzo Life Sciences), 10 ng/mL TGF β1 (R&D System), 50 μg/mL ascorbic acid (SigmaAldrich), 1 mM sodium pyruvate (Hyclone, Thermo scientific), 1×ITS+3 (from SigmaAldrich, contains 1.0 mg/mL insulin from bovine pancreas, 0.55 mg/mL human transferrin
(substantially iron-free), 0.5 μg/mL sodium selenite, 470 μg/mL linoleic acid, 470 μg/mL
oleic acid and 50 mg/mL bovine serum albumin), 2 mM L-glutamine (Hyclone, Thermo
scientific) and 40 μg/mL L-proline (Sigma-Aldrich).42,43
Osteogenic media comprised of DMEM supplemented with 10% FBS, 1×
Penicillin-Streptomycin-Amphotericin B, 10 mM sodium β-glycerolphosphate, 50 μg/mL
ascorbic acid, and 10 nM dexamethasone.
4.4.2 Cell Viability Assay
CellTiter-Blue® (CTB) cell viability assay (Promega) was performed after day 0
(immediately after encapsulation), 3 and 7 of culturing BMSCs in the hydrogels. The
primary media in each well was replaced by 300 μL of pre-warmed media containing 15%
CTB and incubated for 20 h at 37 °C and 5% CO2. The media containing CTB without
cells was used as negative controls. The media containing metabolite of CTB was measured
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for fluorescence intensity at 560/590 nm (Ex/Em) using SpectraMax M2 Multi-Mode
microplate reader (Molecular Devices).
4.4.3 Chondrogenesis Study
After 14 and 28 days of chondrogenic cultures, the samples were fixed in 4%
paraformaldehyde (PFA) for 24 h at 4 °C, dehydrated with a graded ethanol series, and
then embedded in paraffin. For Glycosaminoglycan (GAG) histochemical staining, the
sections, 8 mm in thickness, were stained with Safranin O and Light Green stain following
the literature protocol.44 The stained sections were imaged by a light microscope (Olympus
I×81) under 10× lens at 15 random locations from three stained sections per sample (n =
4). Quantification of the signal intensities of GAG was analyzed with ImageJ. The intensity
of GAG was normalized to the intensity of cytoplasm signal (green).
For the immunohistochemical staining of type II and type I collagen, separate
sections were permeabilized with 0.05% Tween20 in Tris-buffered saline solution (TBS)
for 15 min and blocked in 2% BSA in TBS for 20 min. The separate sections were then
incubated with anti-rabbit collagen type II monoclonal antibody (Sigma-Aldrich) at 1:100
dilution in blocking buffer, or anti-mouse collagen type I monoclonal antibody (SigmaAldrich) at 1:2000 dilution in blocking buffer at room temperature for 2 h. After the
samples were washed thrice with TBS, they were incubated with secondary antibody
detection Alexa Fluor® 546 (for type II collagen) and secondary antibody detection Alexa
Fluor® 488 (for type I collagen) at 1:200 dilution in blocking buffer at room temperature
for 1 h. They were then washed thrice with TBS, and counterstained with DAPI (4, 6diamidino-2-phenylindole, 100 ng/mL) for 15 min. Finally, the sections were mounted for
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microscopic observation. Images of the stained sections were collected using Olympus
I×81 epi-flour mode under 10× lens, exposure times 50 ms for DAPI, 500 ms for collagen
II and I, at 30 random locations from three stained sections per sample (n = 4).
Quantification of the signal intensities of type II and type I collagen were analyzed with
ImageJ. The intensity of type II and type I collagen was normalized to the intensity of
nucleus signal (DAPI).
4.4.4 Osteogenesis Study
Alkaline phosphatase (ALP) activity was determined using pNPP (p-nitrophenyl
phosphate) assay (Thermo Scientific). After 3 and 7 days of induction in the osteogenic
media, the hydrogels with cells were prewashed with PBS then incubated with pNPP
solution at room temperature for 1 h. Absorbance was read using a M2 SpectraMax plate
reader at 405 nm, indicating ALP activity levels. The enzyme activity was calculated from
Beer−Lambert law as follows,
Enzyme activity (µmol⁄ min⁄ construct) =

V(µL) × OD405 nm (cm-1)
ε ×incubation time (min)× construct

where ε is the molar extinction coefficient (M-1 × cm-1). For pNPP, ε = 1.78 × 104 M-1 ×
cm-1, OD405 nm (cm-1) is the absorbance at 405 nm divided by the light-path length (cm),
and V is the final assay volume.45
Alizarin Red S (ARS) staining for Ca2+ was performed after 14 and 28 days of
osteogenic cultures. The hydrogels with cells were washed three times with PBS and fixed
in 4% PFA for 24 h at 4 °C, dehydrated with a graded ethanol series, and then embedded
in paraffin. The sections, 8 mm in thickness, were stained with 0.1% solution of ARS
(Sigma-Aldrich) pH 4.2 for 30 min, washed with PBS to remove excess stain and air dried.
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The stained sections were imaged by a light microscope (Olympus I×81) under 4× lens.
Negative control experiments (before induction in the osteogenic media) were conducted
for all types of the hydrogels.
4.4.5 Statistical Analysis
All quantitative data are expressed as the mean ± standard deviation (SD).
Statistical analysis was performed using ANOVA with Tukey’s multiple comparisons
tests. A value of p < 0.05 was considered to be statistically.
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CHAPTER 5
THE DEVELOPMENT OF HYBRIDIZED-GRAPHENE HA
HYDROGELS AS CONTROLLED PERIVASCULAR DRUG
DELIVERIES FOR VESSEL GRAFT REGENERATION
5.1 INTRODUCTION
Aside from an ideal candidate for tissue engineering applications, hyaluronic acid
(HA) has recently been studied for the use in localized and controlled drug delivery
applications.1-3 It can be used as a macroscopic polymeric system for drug deliveries due
to the unique physical properties, biocompatibility and biodegradability.4 The porosity,
swelling property, permeability of HA hydrogels allows loading of drugs into the hydrogel
matrix and consequent releasing the drugs at a certain rate depended on the diffusion
coefficient of the small molecule through the polymeric network. The hydrogels show
highly flexibility, which is advantageous in immobilizing them at the site of application or
in applying them on surfaces. Nevertheless, HA hydrogels still have several limitations
regarding applications in drug delivery. For example, the hydrogels have restricted capacity
and homogeneity of drug loading, particularly in the case of hydrophobic drugs. The burst
or rapid drug release is often observed in the HA hydrogels due to high water content and
large pore sizes.5 These issues significantly limit the practical use of HA hydrogel-based
drug deliveries in the clinic.
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To overcome the pharmacological limitations of HA hydrogel-based drug
deliveries, modifying the microstructure of the hydrogel,6 incorporation of membranes,7
micelles,8 and nanoparticles,9-11 has been explored to control the diffusion of drugs from
the networks. Particularly, introduction of nanoparticles for controlling drug release has
gained a lot of attraction9,11,12 Graphene oxide is considered as the finest and most durable
nanomaterial. The structure and presence of delocalized surface π electrons in graphene
oxide can be used for drug loading via π–π stacking and electrostatic or hydrophobic
interactions.13-18 In addition, many of the in vivo studies on graphene have demonstrated
its potential to use as drug delivery vehicles,19,20 tissue engineered scaffolds and grafts,21,22
biosensors,23,24 etc.
Currently, treatment of cardiovascular disease by vascular graft is an alternative to
be used to replace or bypass a damaged or occluded vessel. The grafting of autologous vein
vessels represents the gold standard for vascular replacement of diseased small-diameter
(<6 mm) vessels.25 Nevertheless, the vessel patency rates for autologous vein vessel
transplantation remain limited, showing failure rates of approximately 50% at 10 years.25,26
The failures are most commonly associated with thrombosis,27,28 neointimal hyperplasia,2931

atherosclerosis,32 or infection.33,34 So far, no effective strategy exists in clinical practice

to prevent neointimal hyperplasia (NH), which is an overgrowth of cells into the intimal
layer of blood vessels, caused by proliferation and migration of adventitial fibroblasts and
medial smooth muscle cells (SMCs) to the intima. Interestingly, the studies by Cui’s
research lab, our collaborator, have found that the delivery of selective inhibitors of cyclindependent kinase 8 (CDK8), Senexin A, could facilitate the grafted decellularized vessels
into mature arteries after transplantation in vivo, by dramatic suppression of the NH, and
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the formation of SMC layer with sufficient patency up to 3 months. To effectively deliver
Senexin A in vessel regeneration, a localized perivascular delivery approach is logical due
to better targeting and retaining the drug at the vascular site, and preventing off-target drug
effects compared to systemic approach.
Taken together, in this present work, we aimed to establish the efficacy of
optimized Senexin A perivascular delivery using GO-hybridized HA-based hydrogel for
the transformation of decellularized vessel scaffolds into arteries. HA serves as a
biodegradable macroscale polymeric scaffold, making the prepared GO nanocarriers
localized and stable in different microenvironments. The nanocarrier was firstly
synthesized by attaching SNX to GO via strong π–π and electrostatic interaction, followed
by the in situ encapsulation of GO-SNX with HA-based hydrogel. The in vitro drug release
test was determined. The biocompatibility and efficacy of the materials were also evaluated
in vessel smooth muscle cells (VSMCs).

Figure 5.1. Schematic illustration of the experimental research of hybridized-graphene HA
hydrogels as controlled perivascular drug deliveries for vessel graft regeneration.
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5.2 RESULTS AND DISCUSSION
The goals of the development of hybridized-graphene HA hydrogels were: (1) to
control the release of SNX in vitro in therapeutic concentration range of 3-30 µM for 3
weeks or longer, (2) can be biodegradable during vessel regeneration process, and (3) can
effectively transform decellularized vessel scaffolds into mature arteries in vivo in similar
manner to the delivery of SNX without toxicity.
6.2.1 Preparation of Drug-Loaded Graphene Oxide and Drug-Loaded Graphene HA
Hydrogels
The water-soluble GO was firstly synthesized from graphene flake by modified
Hummers’ method.35 The sub-microsized GO was created by further sonication treatment
of the resulted GO, providing a size range of 200 nm–3.5 mm, as verified by SEM imaging
(Figure 5.2A). Fourier transform infrared spectroscopy (FTIR) spectra and physical
appearances of the GO were used to confirm the successful oxidation of graphene.
Specifically, the resulted GO showed the broad characteristic peak of FTIR at 3600–3200
cm-1 which was from the stretching vibration of the OH group. The strong peaks at 1800–
1600 cm-1 were attributed to the stretching vibration of the C=O carbonyl group, and the
bands at 1170, 1090 and 1050 cm-1 were from C–O stretching vibrations. Additionally, the
band at 1625 cm-1 was attributed to unoxidized C=C stretching vibration36,37 (Figure 5.2D).
The resulted GO showed highly water solubility and dark brown color, which were
significantly different from the graphene flake prior to modification (Figure 5.2B, C).
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Figure 5.2. Characterization of the synthesized graphene oxide. (A) Scanning electron
micrograph (SEM) of the synthesized graphene oxide after sonication for 1 h. (B) The
physical appearances of graphene and the synthesized graphene oxide dispersed in PBS.
(C) The physical appearances of graphene and the synthesized graphene oxide after drying.
(D) Fourier transform infrared spectroscopy (FTIR) spectrum of the synthesized graphene
oxide.

The GO was then reacted with SNX at different weight ratio (Figure 5.3A) in PBS
for 24 h at room temperature to generate SNX-loaded GO (GO-SNX). As shown in Figure
5.3D, SNX could attach to GO at different amounts with almost 100% loading efficiency
as determined by UV-Vis. The successful attachment of SNX to GO was further confirmed
by FTIR and UV-Vis spectra (Figure 5.3B, C). Compared with SNX and GO shown in
Figure 5.3B, the FTIR spectrum of GO-SNX at 1:3 loading ratio of GO:SNX showed the
peaks at 3400, 3100–3010, 2260 cm-1 (corresponding to stretching bands of amine N–H,
alkenyl C–H, and nitrile C≡N of SNX) and at 1600 and 900–600 cm-1 (corresponding to
the bending band and wagging bands of amine N–H from SNX), in addition to the weak
characteristic peaks belonging to GO. It should be noted that the observed characteristic
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peaks from SNX were dominant in the FTIR of GO-SNX due to high SNX loading to GO.
Additionally, the UV-Vis spectrum of GO-SNX showed the pronounced absorbance at
both 230, and 323 nm, belonging to the absorbance of GO and SNX respectively (Figure
5.3C).

Figure 5.3. Preparation and characterization of Senexin A-loaded graphene oxide. (A)
Schematic illustrating the preparation of Senexin A-loaded graphene oxide (GO-SNX). (B)
FTIR spectra of GO, SNX, and GO-SNX. (C) Loading efficiency of SNX on to GO at
different weight ratios (n = 3).

The GO-SNX HA hydrogel was formed by simply mixing 3% of MeHA polymer
with 0.1% of GO-SNX in PBS and adding DTT (as shown in Figure 5.4). Without the
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addition of DTT, the mixture of GO-SNX and HA was highly viscous due to the
electrostatic interaction (H-bonding), yet the interaction was not strong enough to create
the hydrogel. The thiol–ene “click” reaction between thiol of DTT and methacrylate group
of HA occurred after adding DTT, resulting in the hydrogel formation.

Figure 5.4. Schematic illustrating the synthesis of Senexin A-loaded graphene HA
hydrogels via thiol–ene “click” reaction.

5.2.2 Gelation time and Mechanical Properties of Senexin A-Loaded Graphene HA
Hydrogels
The gelation time and mechanical properties of the hydrogels are critical for the
application of perivascular wrap for drug delivery system. Owing to the restricted time of
decellularized vessel exposing to air environment, the wrapping process of the hydrogel
onto decellularized vessel is required to complete within 20 min. Specifically, the hydrogel
must be formed within 20 min during the process, and the hydrogel must be highly flexible
and attachable onto the decellularized vessel. In this way, the gelation time and mechanical
properties of GO-SNX HA hydrogels were studied and optimized. The amount of DTT and
GO-SNX were varied in each hydrogel formulation, and the gelation time of each GOSNX HA hydrogels was determined by tilting method. The results showed that increasing
the amount of DTT caused faster gelation time, while increasing the amount of GO-SNX
did not always fasten the gelation time. The impact of GO-SNX concentration to gelation
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time was dependant on the amount of DTT. At lower concentration of DTT (2 and 4 µL/100
µL), high GO-SNX concentration retarded the gel formation time. In contrast, when the
concentration of DTT was high enough, high GO-SNX concentration could shorten the
gelation time to 8-10 min. However, these resulted hydrogels were very rigid, shrink in the
middle of the container, and surrounded by HA solution (shown in Figure 5.5E). It is
because DTT also serve as the reducing agent creating the reduce GO, and later
crosslinking each other to the reduced GO hydrogels instead of GO HA hydrogels. Thus,
the formulation containing low DTT and GO-SNX concentration was selected as the
master recipe for the rest of experiments.
Table 5.1. The gelation time of different Senexin A-loaded graphene HA hydrogels, which
were determined by tilting method. The values expressed are means (n = 4) ± SD.

We further observed the mechanical properties of the hydrogels using rheometer.
The results showed the average complex modulus of the hydrogels was approximately 35
Pa, highly flexible and soft right after gelling. The hydrogels then became more rigid
(approximate 100 Pa) and less flexible after gelling for 3 days (Figure 5.5A-D, F).
Furthermore, the hydrogels were in situ applied on to the decellularized scaffolds by dropcoating technique, as shown in Figure 5.6. The hydrogels were firmly attached on the vessel
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scaffolds, and stable after storage 1 day in PBS, providing a promising result for future in
vivo applications.

Figure 5.5. Physical and mechanical properties of Senexin A-loaded graphene HA
hydrogels. (A, B) Physical appearances of Senexin A-loaded graphene HA hydrogels right
after gelling (C, D) Physical appearances of Senexin A-loaded graphene HA hydrogels
after gelling for 3 days. (E) The formation of reduced GO hydrogels when using high DTT,
6 µL/100 µL. (F) Mechanical properties of Senexin A-loaded graphene HA hydrogels right
after gelling, and after gelling for 3 days. The values expressed are means (n = 3) ± SD.

Figure 5.6. The attachment of Senexin A-loaded graphene HA hydrogels to the
decellularized scaffolds in PBS after gelling (A) and 1 day (B).

5.2.3 In Vitro Drug Release of Senexin A-Loaded Graphene HA Hydrogels
We next evaluated whether SNX could be delivered and controllably released from
the hybridized GO-HA hydrogels. Drug release from a GO nanocarrier depends on
different factors, such as pH,38 GO sizes, and interactions between drug and GO carriers.
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In the study, in vitro release behavior of SNX from GO-SNX HA hydrogels was
investigated at 37 °C in PBS and DMEM media with pH 7.4, representing normal
physiological pH. The release of SNX from SNX loaded HA hydrogels was also studied
for comparison. It showed that the SNX released from the GO-SNX HA and SNX-loaded
HA hydrogels reached equilibrium within 2 h at a concentration of 100 µM and 200 µM in
PBS, respectively (Figure 5.7A). The release of SNX from the GO-SNX HA systems
maintained constantly, while the release from the SNX loaded HA hydrogels tended to
slow down after 2 days of the study (Figure 5.7B). The cumulative release of SNX from
SNX loaded HA-based hydrogels was 3 times higher than that in GO-SNX HA hydrogels
after 5 days of the study (Figure 5.7C). These results can be ascribed to the strong
hydrogen-bond and π-π stacking interactions between SNX and GO at pH 7.4 media which
slowed down the release of SNX from the networks.39-41

The release concentration of SNX from GO-SNX HA systems was further
optimized to reach the therapeutic window, ranging from 3 -30 µM. Several methods were
used to optimize the release of SNX, such as increasing polymer density, modifying GO
surface, and varying the loading ratios of GO to SNX. It was found that lower the SNX
loaded onto GO could significantly slow down the drug release (shown in Figure 5.7D).
The 4:1 loading ratio of GO to SNX was found to be optimal for a controlled release of
SNX at ~ 30 µM, and it could facilitate the constant release of SNX for 17 days (Figure
5.8A). Before completion of the release profile, the SNX release became higher, suggesting
that the degradation of HA polymer was involved. The completion of release was in 22
days (Figure 5.8B).
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Figure 5.7. In vitro SNX release profiles of Senexin A-loaded graphene (GO-SNX) HA
hydrogels. (A) In vitro SNX release profiles of GO-SNX HA hydrogels compared to SNX
loaded HA hydrogels in first 5 hours of incubation in PBS at 25 oC. The values expressed
are means (n = 3) ± SD. (B) In vitro SNX release profiles of GO-SNX HA hydrogels and
SNX loaded HA hydrogels for 5 days in PBS at 37 oC. The values expressed are means
(n = 3) ± SD. (C) In vitro cumulative release profile of SNX from GO-SNX HA hydrogels
and SNX-loaded HA hydrogels calculated from Figure (B). The values expressed are
means (n = 3) ± SD. (D) Influence of the loading ratio of GO:SNX (1:3, 1:1, and 4:1) on
in vitro SNX release profiles of GO-SNX HA hydrogels in PBS at 25 oC. The values
expressed are means (n = 3) ± SD.

Figure 5.8. In vitro SNX release profiles of GO-SNX (4:1) HA hydrogels. (A) In vitro
SNX release profiles of GO-SNX HA hydrogels using 4:1 loading ratio of GO:SNX in
PBS at 37 oC. The values expressed are means (n = 3) ± SD. (B) The cumulative release
profile of SNX from GO-SNX HA hydrogels shown in (A). The values expressed are
means (n = 3) ± SD.
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To describe the possible controlled release mechanisms and estimate SNX release
rate constant from the GO-SNX HA hydrogels, the release kinetics of SNX from the
systems were analyzed using different kinetic models for controlled drug delivery systems,
including zero order, first order, and Higuchi model equations.42 As shown in Figure 5.9,
5.10 and Table 5.2, it obviously confirmed that the release of SNX form HA and GO-HA
hydrogels were not followed by neither zero order nor Higuchi kinetic model. First-order
release kinetic model was the best fit for the SNX release from HA and GO-SNX HA
hydrogels (R2 ~ 0.95-0.98). It refers that the SNX release rate depends on its concentration
in the hydrogel scaffold. Korsmeyer-Peppas model was further used to confirm the exact
release mechanism. This kinetic model is widely used for study the release mechanism
from complex polymeric systems.43 As shown in Eq (4), the mechanism of drug release
from Korsmeyer-Peppas model is indicated by the release exponent (n). Namely, the case
of n ≤ 0.45 corresponds to a Fickian diffusion (diffusion-controlled drug release), 0.45 <
n < 0.89 corresponds to a non-Fickian transport (refers to the combination of diffusion and
erosion controlled rate release), n = 0.89 corresponds to Case II transport (erosioncontrolled drug release), and n > 0.89 corresponds to super case II transport mechanism.
The relationship of the n values from fitting data of the SNX release from GO-SNX HA
hydrogels and loading ratio of GO:SNX incorporated in the hydrogels was observed. The
higher ratio of GO:SNX (more SNX loaded to GO) incorporated into hydrogels, the less n
values observed from fitting data to Korsmeyer-Peppas model. Specifically, the n values
from fitting data of the SNX release from GO-SNX HA (4:1) hydrogels were equal to
0.5445, which refers to the combination of diffusion and erosion controlled rate release
mechanism. Meanwhile, the n values from the fitting data of the SNX release from GO128

SNX HA (1:1), and GO-SNX HA (1:3) hydrogels decreased to 0.3678, and 0.2764,
respectively, matching to diffusion-controlled rate release mechanism.
Using these mathematical kinetic models, it could simplify that the SNX release
were mainly driven by diffusion and erosion and depended on SNX concentration loaded
to GO. Due to the fact that HA generally remains stable under physiological pH and
temperature, and undergo dissolution in the aqueous medium due to solvent penetration
effect, swelling, and polymer chain disentanglement and relaxation.44 Thus, solute
transport from HA-based material systems could be driven by diffusion and/or dissolution.
Likewise, HA is a biodegradable polymer which can be degraded under extreme pH and
temperature, various proteins, cells, and enzymes.45 As a result, the drug release from HA
systems could be also forced by erosion. More importantly, the SNX release rate is
depended on drug loading concentration which refers to loading ratio of GO:SNX. Due to
the interaction between the SNX and GO components, the SNX release rate could be
retarded by GO from the material systems.
Table 5.2. Correlation coefficient (R2), rate constant (K), and release exponent (n) values
obtained by fitting the data of the release of SNX from different hydrogel formulations into
PBS at pH 7.4.
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Figure 5.9. Fitting of the data for SNX release from the SNX loaded HA hydrogels (SNXHA) and GO-SNX HA hydrogels having different loading ratio of GO:SNX (1:3, 1:1, and
4:1) into PBS (pH 7.4) to the zero order (A) and first order kinetics (B).
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Figure 5.10. Fitting of the data for SNX release from the SNX loaded HA hydrogels (SNXHA) and GO-SNX HA hydrogels having different loading ratio of GO:SNX (1:3, 1:1, and
4:1) into PBS (pH 7.4) to the Higuchi release model (A) and Korsmeyer-Peppas release
model (B).
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5.2.4 In Vitro Cytocompatibility and Efficacy of Senexin A-Loaded Graphene HA
Hydrogels
Cytotoxicity is one of the most important properties of biomaterials for drug
delivery, we thus investigated the cytotoxicity of our prepared SNX-GO HA hydrogels. It
is satisfying to find that after incubation for 1 and 3 days, the incorporation of GO-SNX
HA hydrogels showed no cytotoxicity compared to the control 2D cells based on CelltiterBlue assays (Figure 5.11A, B). However, the in vitro long-term effects of the materials,
particularly the effects of GO, should be considered in the future study. Previously, the
interaction between dispersed graphene or GO sheets and lung epithelial cells, fibroblasts
and neuronal cells has been studied in monolayer cultures. It was reported that single-layer
GO sheets were internalized and sequestered in cytoplasmic, membrane bound vacuoles
by human lung epithelial or fibroblast cells. and induced toxicity at doses above 20 µg/mL
after 24 h. Additionally, GO and pristine graphene are both recognized to be ingested by
macrophages, inducing cell activation and secretion of pro-inflammatory cytokines.46-49
These effects were reported to be depended on the geometry of the used graphene. The
larger flakes (approximately 2 µm) provoked a significantly increased secretion of
inflammatory cytokines by macrophages in vitro compared to the smaller flakes
(approximately 350 nm).50 Therefore, the further optimization of GO lateral sizes for long
term safety of GO-SNX HA hydrogels should be our next step of the development.
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Figure 5.11. In vitro cytocompatibility and efficacy of Senexin A-loaded graphene HA
hydrogels. (A) Cell viability of VSMCs after culturing in primary media with GO-HA
hydrogels or GO-SNX HA hydrogels or without any hydrogel for 24 h using Celltiter-Blue
assay. The data was normalized to the cell viability intensity of 2D cell culture (positive
control). The values expressed are means ± SD, n = 3 with two repeated experiments. (B)
Cell proliferation of VSMCs after culturing in DMEM media with 2% FBS for 24 and 72
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h using Celltiter-Blue assay. The data was normalized to the cell viability intensity after 24
h culturing of each sample. The values expressed are means ± SD, n = 3 with two repeated
experiments (C) Analysis of VSMC migration by in vitro scratch assay after culturing with
GO-HA hydrogels or GO-SNX HA hydrogels or without any hydrogel until confluency.
Images were acquired at 0, 24, and 48 h after incubation in DMEM media with 2% FBS
using phase-contrast microscope. (D) Average wound distances of the scratch closures
from (C) measured by Infinity Analyze software. The values expressed are means ± SD,
n = 4, with 72 reading of distance for three repeated experiments. (E) Western blot analysis
showed the expression of smooth muscle-specific SM22, alpha-smooth muscle actin (αSMA) GAPDH and β-actin protein in VSMCs after treatment in serum-free medium for 48
h and later in complete medium with GO-HA hydrogels or GO-SNX HA hydrogels or
without any hydrogel for 24 h, n = 3 with two repeated experiments.

The efficacy of GO-SNX HA hydrogels for suppression of neointima was evaluated
by observing their impacts on proliferation, migration, dedifferentiation of VSMCs. Due
to the fact that, during the graft occlusion process, VSMCs of “contractile” phenotype
commonly migrate to the lumen of the graft and transform to a “synthetic” phenotype,
proliferating and secreting ECM proteins to form a neointima.51 The disappearance of SMC
phenotype proteins is generally taken as characteristic of the synthetic phenotype of
VSMCs, which could be observed in the dedifferentiation process of VMSCs.52,53 Herein,
we hypothesized that the GO-SNX HA hydrogels could suppress the neointima formation
in the similar way to the treatment of SNX observed by Cui’s research (data not was not
shown). As expected, the materials (both GO-HA hydrogels and GO-SNX HA hydrogels)
showed no significantly difference in the proliferation and migration of VSMCs compared
to culturing without the materials (Figure 5.11A-D). More importantly, the GO-SNX HA
hydrogels could successfully inhibit the dedifferentiation of VSMCs after the starvation
for 48 h by maintaining the expression of smooth muscle-specific proteins, including SM22
and alpha-smooth muscle actin (α-SMA) (Figure 5.11E). In contrast, without the
incorporation of GO-SNX HA hydrogels, the VSMCs expressed significantly lower
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amount of smooth muscle-specific proteins as the starvation promotes VMSC
dedifferentiation.54,55 The GAPDH and β-actin protein used as the positive controls showed
no significantly difference between VSMCs treated with or without the GO-SNX HA
hydrogels. However, we observed that the VSMCs treated with GO-HA hydrogels after
starvation revealed the lower amount of SM22 and GAPDH compared to the proteins
expressed by VSMCs without the hydrogels. It is likely that the materials itself may impact
on the dedifferentiation process. Hence, we further observed the impact of each component
of the hydrogels, including HA, DTT, and GO, on the cellular protein expressions of the
starved VSMCs. As shown in Figure 5.12, the expression of SM22, α-SMA, GAPDH and
β-actin proteins significantly depleted only in the starved VSMCs treated with HA
components. The result could be explained by the observation from Song et al., which
found that the overexpression of hyaluronic acid by mouse SMCs promoted the progression
of atherosclerosis by modulating SMC phenotypic towards the synthetic phenotype.56

Figure 5.12. Western blot analysis showed the expression of smooth muscle-specific
SM22, alpha-smooth muscle actin (α-SMA) GAPDH and β-actin protein in VSMCs after
treatment in serum-free medium for 48 h and later in complete medium without or with
HA (3 mg/mL) or 0.5M DTT (2µL/mL) or GO (1mg/mL) for 24 h, n = 3.
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Taken together, we found that the hybridized GO-HA hydrogels could be used for
prolonged delivery of SNX and provided well efficacy with high biocompatibility.
However, in order to use GO-SNX HA hydrogels in real world clinical applications, there
are several aspects should be further addressed; first, the in vivo efficacy and safety in longterm duration; second, whether the HA system is an ideal to serve as the polymeric system
for vessel graft regeneration. Based on our in vitro dedifferentiation results, it also
suggested us that other systems, such as fibrillar collagen type I, and collagen type IV, may
be considered as an alternative for vessel graft regeneration application since they have
been shown to promote the contractile phenotype of VSMCs.57
5.3 CONCLUSIONS
A GO hybridized HA hydrogel as a perivascular drug delivery wrap was created.
The hydrogel could control the release of SNX over 21 days, could be tunable to provide
different drug release rates by varying the amount of the loaded drug onto GO into a
hydrogel, and was biocompatible and provided well efficacy in vitro. The GO hybridized
HA construct was found to very flexible and highly attachable to decellularized scaffolds
for in vivo placement. This study revealed a novel interaction of the of Senexin A with
graphene oxide in HA based hydrogels, which could be used for prolonged delivery of
aromatic small molecule drugs. The presented GO hybridized HA constructs provide an
optimistic outlook for their successful use in perivascular drug delivery system for the local
treatment of vascular graft neohyperplasia.
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5.4 MATERIALS AND METHODS
5.4.1 Preparation of Graphene Oxide Nanosheets
Graphene oxide nanosheets were synthesized following the previous reports.36,58
Briefly, 1 g of dried graphite flakes (Graphene Supermarket®) was dispersed in 50 mL of
concentrated sulfuric acid while stirring at 0 οC (ice bath). 3 g of potassium permanganate
(>99%, Sigma Aldrich) was slowly added into the suspension. After that, the suspension
was stirred at room temperature for 25 min and sonicated in ultrasonic bath for 5 min,
repeating this stirring and sonication process for 12 cycles. 200 mL of distilled water was
then added to quenched the reaction. The suspension was further sonicated for 2 h to obtain
graphene oxide nanosheets (GO). Then, the GO was washed following a modified
Hummers’ method. Briefly, 20 mL of hydrogen peroxide (30%, Merck) was added into the
GO suspension while stirring until released gas stopped. 1M hydrochloric acid was used
for washing the GO precipitates by centrifugation for 3 times at 10000 rpm for 30 min, and
followed by distilled water for 3 times with the same method. The final GO precipitates
were dried in the oven at 40 οC for several days.
5.4.2 Preparation of Drug-Loaded Graphene Oxide
Senexin A (SNX) (1, 2, 3 mg) and GO (1 mg) were added to 3 mL PBS (pH 7.4)
(sonicated together for 1 h) and stirred for 20 h at room temperature in darkness. The
product (SNX-GO) was collected by repeated centrifugation at 12000 rpm 5 min and
washing with PBS until the supernatant became color free. The resulted SNX-GO was
freeze-dried. The amount of unbound SNX was determined by measuring the absorbance
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at 323 nm relative to a calibration curve recorded under identical conditions, allowing the
drug loading efficiency to be estimated.
To quantify free SNX, the centrifuged solution was collected and diluted to 100 mL
with deionized water in a flask. The amount of free SNX was determined by a UV–VIS
spectrometer at wavelength of 323 nm. The SNX-loading efficiency was calculated as
follows:
SNX-loading efficiency % = 100 (WfeedSNX−WfreeSNX)/ WfeedSNX
5.4.3 Characterization of Graphene Oxide and Drug-Loaded Graphene Oxide.
GO and SNX-GO were characterized by UV−vis spectrophotometry (Nanodrop
2000), Fourier transform infrared (FTIR) (Spectrum-GX, PerkinElmer), Scanning Electron
Microscope (Zeiss Ultraplus Thermal Field Emission SEM).
5.4.4 Formation of Drug-Loaded Graphene HA hydrogels
Prior to formation of the SNX-loaded GO HA hydrogels, methacrylated modified
HA polymer at approximately 50% modification (50DM MeHA) was firstly synthesized
following our previous reports.59,60 The SNX-GO was dispersed in the medium (PBS or
DMEM) at 0.1% w/v by sonication for 2 h. The 50DM MeHA was then added into the GOSNX suspension at concentration of 3%. After the polymer completely dissolved in GOSNX mixture, 0.5 M DTT was added into the mixture to form the hydrogel.
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5.4.5 Gelation Test
The hydrogels were prepared previously described by using PBS as the medium.
The gelation time was measured by the vial tilting method.61 When the sample showed no
flow within 20 s, it was considered as being completely formed hydrogel.
5.4.6 Mechanical Test
Complex modulus of the SNX-loaded GO HA hydrogels was performed using a
DHR-3 rheometer (TA instrument) with 12 mm diameter parallel-plate geometry and
temperature controlled Peltier plate. The hydrogels were prepared previously described by
using DMEM as the medium. After gelation, the samples were cut into uniform cylinders
and placed on a metal plate, where the tests were performed. Amplitude sweeps at constant
frequency (1 rad/s) were performed to determine the linear viscoelastic range of
deformation for each sample, after which frequency sweeps (0.1-10 rad/s) were performed
at a strain amplitude within the linear range (1%). In amplitude and frequency sweeps
measurement, the geometry gaps were conditioned by axial force at 0.2 N for every run.
5.4.7 Attachment of Senexin A-Loaded Graphene HA Hydrogels on Decellularized
Scaffolds
The preformed GO HA or GO-SNX HA hydrogels (after preparation for 10 min)
at 10 µL was used to coat around the decellularized vessel scaffolds. The images were
taken after incubation in PBS for 20 min and 1 day at 4 οC.
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5.4.8 In Vitro Drug Release
Constructs were incubated at 37 °C with gentle shaking in 96-well plate with 100
µL of release DMEM medium. Sample medium was removed and replaced daily (every 24
h) at equal volume. The release profile of SNX from the GO-HA hydrogels was performed.
The content of the released Senexin A in the withdrawn medium was determined by UVvis spectra. The drug release was conducted for 21 days. Before performing UV-vis
absorption experiments, a standard curve of Senexin A concentration versus absorption
peak intensity (at 323 nm) will be established.
5.4.9 Release Kinetics of Senexin A from Drug-Loaded Graphene HA Hydrogels
Constructs were incubated at 25 °C in 96-well plate with 100 µL of PBS. Sample
medium was collected at 5 µL for performing UV-vis, and replaced back to the well plate
at different time points (5, 10 15, 20, 30, 45, 60, 90, 120, 180 min, and 24 h). The release
kinetics of SNX from the systems were analyzed using different kinetic models for
controlled drug delivery systems, including zero order, first order, Higuchi, and
Korsmeyer-Peppas model equations:42
Zero-order release model:

Qt = K0 t

Eq (1)

First-order release model:

ln (100 – Qt) = ln100 − K1t

Eq (2)

Higuchi release model:

Qt = Kh t1/2

Eq (3)

Korsmeyer-Peppas model:

Qt/Qe = K tn

Eq (4)

where Qt is the percentage of drug released at time t; Qt/Qe is the fraction of the SNX
released at time t; K0, K1, Kh and K represent the zero-order release kinetic constant, the
first-order release kinetic constant, the Higuchi release kinetic constant and the Korsmeyer-
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Peppas kinetic constant incorporating structural and geometric characteristics of the
hydrogel, respectively; and n is the release exponent, indicative of the mechanism of drug
release. Namely, the case of n ≤ 0.45 corresponds to a Fickian diffusion (diffusioncontrolled drug release; the rate of release is independent of the drug concentration in the
hydrogels.), 0.45 < n < 0.89 to a non-Fickian transport, n = 0.89 to Case II transport
(erosion-controlled drug release), and n > 0.89 to super case II transport mechanism. When
determining the n exponent, only the portions of the release curve where Mt ≤ 60% were
used.
5.4.10 Vascular Smooth Muscle Cell (VSMC) Isolations and Cultures
Briefly, the aortic arch and root (1.5 cm in length) from male 8-week-old C57BL/6J
mice were removed. After aortic isolation, vessel was cleaned of any connective tissue by
gently scraping with forceps. After, the aorta was enzymatically digested for 10 min at 37
o

C with 7.5 mg collagenase type 2 (Worthington) in 5.5 mL GibcoTM DMEM High

Glucose containing 10% fetal bovine serum (FBS). Stopped digestion with cold 10% FBS
DMEM High Glucose, then stripped the adventitia from the aorta under microscope. Cut
the media into small pieces, digested with rocking, and filtered (for 70 min). Cells in the
filtrate were pelleted at 300g for 8 minutes, then rinsed in DMEM High Glucose containing
20% FBS, penicillin (100 U/mL) and streptomycin (100 mg/mL). Cells were cultured and
incubated for 6-7 days. Medium was changed every 2 days. After first passage, the mouse
VSMCs were then maintained in DMEM High Glucose supplemented with 20% FBS,
penicillin and streptomycin at 37 oC in a humidified atmosphere with 5% CO2.
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5.4.11 In Vitro Cytocompatibility for Senexin A-Loaded Graphene HA Hydrogels
CellTiter-Blue (CTB) cell viability assay (Promega) was performed after 1 day of
culturing VSMCs on 96-well plate with SNX-Loaded GO HA Hydrogels or GO-HA
hydrogels or without any hydrogels. The culture media in each well was replaced by 200
mL of prewarmed media containing 15% CTB and incubated for 2 h at 37 °C and 5% CO2.
The media containing CTB without cells was used as negative controls. The media
containing metabolite of CTB was measured for fluorescence intensity at 560/590 nm
(Ex/Em) using SpectraMax M2Multi-Mode microplate reader (Molecular Devices).
5.4.12 In Vitro Efficacy Test for Senexin A-Loaded Graphene HA Hydrogels
5.4.12.1 Proliferation of VSMCs
Proliferation of VSMCs was firstly performed to test the efficacy of the hydrogels
by CTB cell viability assay after culturing with the hydrogels for 3 days in DMEM media
with 2% FBS supplement. The proliferation of VSMCs was quantified by normalization
their fluorescence intensities at 560/590 nm to their intensities after 24 h (n= 3 with two
repeated experiments).
5.4.12.2 Migration of VSMCs
Migration of VSMCs was determined by in vitro scratch assay following the
previous protocol.62 Briefly, VSMCs were seeded on 24-well plate at 50,000 cells per well
in 1 mL of complete growth medium with GO-HA hydrogels, or GO-SNX HA hydrogels,
or without any hydrogels, and cultured them until confluency. The cells were then scrape
in a straight line with a sterile p200 pipet tip. The debris was removed by washing the cells
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once with 1 mL of the growth medium and them replace with 1 mL of DMEM with 2%
FBS supplement. After 0, 24 and 48 h of incubation, the straight line was randomly imaged
under phase-contrast microscope (Olympus CKX41) for 6 images per well (n= 4 with three
repeated experiments). The images were further analyzed quantitatively by using Infinity
Analyze software. Each image, the distances between one side of scratch and the other
were measured at certain intervals (µm) for 3 readings.
5.4.12.3 Dedifferentiation of VSMCs
Dedifferentiation of VSMCs was also studied to access the efficacy of the
hydrogels. VSMCs were seeded on 24-well plate at 10,000 cells per well in 1 mL of
complete growth medium, and cultured until confluency. After that, the medium in each
well was replaced with serum-free DMEM medium to starve the cells for 48 h. The starved
VSMCs were then incubated in complete growth medium with GO-HA hydrogels, or GOSNX HA hydrogels, or without any hydrogels for 24 h. Total protein extracted from
different batches of cultured VSMCs were lysed with ice-cold RIPA lysis buffer (Alfa
Aesar), agitated for 1 h on ice, then centrifuged at 14,000× g at 4 οC for 15 min, and the
supernatant was collected and aliquoted. The protein concentration was determined with a
Lowry assay kit according to the manufacturer’s instructions (Bio-rad). Equal amounts of
total protein (30–50 µg) were subjected to SDS/PAGE under reducing conditions and then
electrotransferred to polyvinylidene difluoride membrane (Millipore). The efficacy of
protein loading and transfer to membranes was also assessed by Ponceau S staining. The
membranes were blocked with 5% nonfat milk (Bio-rad) in Tris-Buffered Saline-0.05%
Tween 20 (TBST) for 1 hour at room temperature and incubated with primary antibody
against SM22, SMA, GAPDH, or β-actin overnight at 4 οC, then incubated with a
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horseradish peroxidase conjugated secondary antibody (1:5000) for 1h at room
temperature. Blots were visualized using SuperSignal® West Femto Maximum Sensitivity
Substrate (Pierce) and CL-XPosure™ Film (Pierce).
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APPENDIX F – THE DEVELOPMENT OF GRAPHENE-FET
NANOSENSOR FOR SMALL-MOLECULE DETECTION
This present work was a part of collaborive research with Dr. Qiao Lin, Columbia
University (New York), Department of Mechanical Engineering.
1.1 INTRODUCTION
Single layer graphene (SLG), a layer of carbon atoms bonded together in a
hexagonal honeycomb lattice, is emerging as an attractive functional nanomaterial in
chemical and biological sensors. Previously, we have functionalized SLG bonded on a field
effect transistor (FET) nanosensor with a boronic acid-derivatized pyrene via π-π
interaction for glucose recognition. The sensors could effectively measure glucose
concentration in a practically relevant range of 2 μM to 25 mM through the changes in the
electric conductance of graphene which observed by the shifts of transfer characteristics.1
Inspired by this work, we hypothesized that the change in electronic transfer properties of
graphene is strongly related to the types and sizes of functional groups, density of
modification, and the pH of the environment. Modification of graphene with the appropiate
functional groups at high density will create a higher sentivity of graphene-FET
nanosensors for glucose and other small molecule detection.
Herein, two strategies for molecular functionalization of SLG, including noncovalent and covalent modification, were applied to understand the effect of functionalized
molecules and their densities on charge transfer characteristics, which is the key
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consideration for improving the sensitivity of FET devices. For the non-covalent strategy,
we used pyrene derivatives carrying different electron withdrawing/donating functional
groups to interact with the graphene via π-π interaction. The different length sizes of
functional groups of pyrene derivatives were also used to interact with the graphene in
order to study the effect of functional group sizes on the sensitivity of charge transfer
characteristics (Figure 1) The different electron withdrawing/donating aryl radicals was
also colvantly functionalized on the SLG by electrografting method. The different
controllable densities of functional aryl groups were also created by varying the amount of
electro-reaction cycles (Figure 2). The shifts of charge transfer characteristics from these
different modified functional group SLG on FET devices will be observed.

Figure F.1. The schematic illustration of the non-covalent strategy to functionalize single
layer graphene to improve the sensitivity of the detection. The pyrene derivatives carrying
different electron withdrawing/donating functional groups and different length sizes were
interacted to the graphene via π-π interaction.
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Figure F.2. The schematic illustration of the covalent strategy to functionalize single layer
graphene to improve the sensitivity of the detection. The electrografting of different
functionalized aryl radicals at different densities was used to covalently modify the single
layer graphene.
1.2 RESULTS AND DISCUSSION
Based on our previous report, the recognition of glucose by a graphene-based
affinity nanosensor was due to the formation of glucose-boronate ester, which could reduce
the boronic acid-induced p-type doping in the graphene.1 In particular, at pH 7.4, most of
the pyrene boronic acid motifs remain neutral as a sp2 hybridized electron configuration
(the pKa of pyrene boronic acid (pKa-acid) was reported approximately 8.8.2). Upon
anchoring on the surface of graphene, the empty p-orbital of boron will offer a strong
electron withdrawing effect to deprive the electrons from graphene, resulting in a strong pdoping effect. When glucose molecules are introduced in the system, pyrene boronate
esters will be formed which favors the equilibrium towards a sp3 hybridization (Figure
3B).3,4 As such, the boron atom no longer exhibits an empty p-orbital; instead, it becomes
an electron rich sp3 configuration, leading to a profound n-doping effect on the graphene
upon glucose binding. We believe that the sensitivity of doping effect alteration on this
graphene devices can be improved or modified by changing the functional motifs.
Specifically, introduction of strongly electron withdrawing/donating groups at high density
on graphene-FET devices, creating a strongly p-doping/n-doping effects, may enhance the
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responsiveness after binding to the detected molecules compared to introduction of weaky
or neutral functional groups at low density.

Figure F.3. (A) The relationships between sp2 and sp3 pyrene boronic acid in 0.10 M
phosphate buffer (pH 7.4). Ka-acid is the dissociation constant of pyrene boronic acid. (B)
Boronate ester formation and the relationships between pyrene boronic acids and their
boronate esters in 0.10 M phosphate buffer (pH 7.4) with glucose. K eq is the association
constant of boronate ester. Ka-ester is the dissociation constant of pyrene boronate-glucose
ester.
Here we report the sucessfully modification of strong electron withdrawing and
donating aryls (nitro- and amino- aryls, repectively) onto SLG via electrografting method.
First, SLGs grown via a chemical vapor deposition (CVD) process were transferred onto
silicon substrates using a nondestructive polymer-mediated (PMMA) transfer technique.5
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Cyclic voltammetry (CV) experiments were performed in an electrolytic cell containing 2
mM of (4-nitrophenyl) diazonium tetrafluoroborate (NDTB) in 0.1 M H2SO4 solution by
using SLGs as the working electrode with the aid of Cu metal (as shown in Figure 4). A
broad irreversible wave located at − 0.2 V (vs. Ag/AgCl) was observed at a scan rate of 0.2
V/s which indicated that nitrophenyl groups were grafted to the surface of SLGs. When the
CV performed at range of 1 V – (-1)V, the additional broad irriversible wave at − 0.5 V
(vs. Ag/AgCl) was observed. This wave corresponds to the reduction of nitro group to
amino groups which confirmed that aminophenyl groups were created to the surface of
SLGs.. The atomic force microscopy (AFM) was further used to prove the formation of a
compact nitro-/ amino-phenyl layer. The AFM image revealed an obvious differences
between pristine and modified SLGs (Figure 6A). The surface modification was calculated
based on Faraday’s law. By integration of the electrochemical current from data in Figure
5A and B, a surface concentration of grafted nitrophenyl and aminophenyl groups was
approximately 2-4 × 10-8 mol/cm2 (Figure 5C, D).

Figure F.4. The electrolytic cell used for diazonium electrografting of graphenes. WE
represents working electrode (SLG) ; CE represents counter electrode (Pt) ; RE represents
reference electrode (Ag/AgCl ).
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Figure F.5. Characterization of the modification of the functional groups on single layer
graphene. A, C) The cyclic voltammogram and surface coverage calculation of nitro aryl
modified graphene. B, D) The cyclic voltammogram and surface coverage calculation of
amino aryl modified graphene.

Figure F.6. Surface characterization of the modified single layer graphene (right)
compared to the non-modified single layer graphene (left) by AFM (A) and SEM (B).
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1.3 FUTURE DIRECTIONS
To further confirm the successful diazonium electrografting of graphenes, raman
spectroscopy and X-ray photoelectron spectroscopy (XPS) studies should be used to
characterize the modified graphene surfaces. The study of the doping effect and
responsiveness of the resulted graphene-based affinity nanosensors will be the next step of
the experiments. We expect that the p- and n-doping effect will be observed from -0.5V
samples (NO2 group) and -1V samples (NH2 group), repectively. The higher surface
coverage of the modifed aryls will provide higher sensitity of the detection.
1.4 MATERIALS AND METHODS
1.4.1 Modification of Single Layer Graphene by Electrografting Method
The graphene sheets (0.5 × 0.5 cm) on SiO2 wafer as the working electrode was
immersed into the electrochemical cell. The platinum (Pt) was used as a counter electrode,
and Ag/AgCl was used as a reference electrode. The electrolyte solution containing 2 mM
of (4-nitrophenyl) diazonium tetrafluoroborate (NDTB) in 0.1 M H2SO4 solution was
added in the cell at volume of 15 cm3. Prior to performing the electrochemical reactions,
the system was purged by a stream of nitrogen gas for 10 min to remove any trace of air or
oxygen in the cell. Voltammetric measurements were performed using CHI 660A
electrochemical workstation ll. The cyclic voltammograms (1V – (-1)V and 1V – (-0.5V))
were observed at a scan rate of 0.2 V/s and room temperature.
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1.4.2 Characterization of the Modified Single Layer Graphene
After the electrochemical reactions, the modified SLGs were prepared for
characterization by rinsing with abundant amounts of de-ionized (DI) water three times to
completely remove diazonium salts that had been physically absorbed onto the graphene
surface. After that, atomic force microscopic (AFM) images were performed using a
Nanoscope IIIA Scanning Probe Microscope with silicon cantilevers in the tapping mode.
Scanning Electron microscope (SEM) images of the modified SLGs were also obtained by
Zeiss Ultraplus Thermal Field Emission SEM at 5 kV.
1.4.3 Calculation for the Modified Surface Concentration
The surface concentration was calculated following this equation;
Γ=q/nFA
Where q = charge of the peak [C], n = number of electrons involved in the redox
process, F = Faraday constant [C/mol], A = area of the electrode [cm2], Γ = surface
concentration on the electrode [mol/cm2].6
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